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ABSTRACT 
Uncontrolled hemorrhage is the leading cause of preventable traumatic death in 
both military and civilian populations. Hemorrhage often causes coagulopathy, 
which intensifies hemorrhage and complicates its treatment. The armed conflicts 
in Afghanistan and Iraq have allowed the military to test new hemostatic products 
and procedures in an effort to better control hemorrhage and reduce its 
associated morbidity and mortality rates. These methods were analyzed for 
efficacy and suitability in the civilian prehospital setting. Several invasive and 
non-invasive interventions were found to be beneficial. Despite centuries of 
controversy surrounding their use, emergency tourniquets can be safe , life-
saving tools for controlling severe extremity hemorrhage when adequate 
tourniquet designs are properly used. Hemostatic dressings are very useful as 
hemorrhage control adjuncts, and two products (Combat Gauze and Celox) are 
recommended for prehospital use based on their efficacy, mechanisms of action, 
ease of use, low cost, shelf-life , and other properties. Several pharmacological 
interventions were evaluated for prehospital use in addressing the anticoagulant 
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and hyperfibrinolytic nature of trauma-associated coagulopathy. Recombinant 
activated Factor VII, commonly used in hemophiliac-related bleeding , does not 
improve outcomes in trauma patients. Tranexamic acid, which is commonly used 
to reduce bleeding in elective surgeries , has been demonstrated to significantly 
lower mortality in trauma patients with severe hemorrhage, especially when 
administered within three hours of injury. Recommendations were also made 
based on the results of military-developed damage control resuscitation 
protocols : restoration of perfusion is the best way to correct coagulopathy and 
prehospital fluid administration should be limited to restore perfusion and 
maintain systolic blood pressures of 80 to 90 mmHg. Hypothermia and 
hyperthermia are correlated with higher mortality in trauma patients, so 
temperature management was identified as a top priority in prehospital trauma 
care. Finally, the properties of stored blood were investigated in the setting of 
massive transfusion so that paramedics conducting interfacility transfers of these 
patients could be made aware of common complications to anticipate adverse 
events. 
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INTRODUCTION 
Objectives 
Following the terrorist attacks of September 11 , 2001 , the United States 
committed combat forces to Afghanistan (Operation Enduring Freedom (OEF)) in 
October 2001 and to Iraq (Operation Iraqi Freedom (OIF)) in March 2003. The 
intensity and weaponry of these conflicts have resulted in severe trauma that has 
challenged military medicine to adapt. The resultant advancements in 
technology, procedures, and doctrine have greatly improved survival rates from 
these injuries. In particular, there have been several key evolutions in the 
management of hemorrhage control. 
This thesis aims to evaluate these combat hemostasis methods for their 
effectiveness and suitability for use in civilian , prehospital emergency medical 
care. At the first responder and EMT -Basic levels, there are non-invasive 
interventions such as tourniquets and topically-applied hemostatic dressings. In 
addition to these hemorrhage control tools, there are several invasive 
interventions like pharmacological agents and fluid resuscitation . There are also 
other important aspects of hemostasis to consider, including temperature 
management and massive transfusion patients . While it is unlikely that blood 
products will be administered prehospitally as a matter of course , EMT-
Paramedics are frequently utilized to perform interfacility transfers of unstable or 
marginally-stable patients . Thus , this thesis will also examine how the 
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advancements in combat-derived medical knowledge and treatment can be 
translated into preparatory training for transporting patients following episodes of 
significant hemorrhage. 
Relevance of Military Trauma Care 
Prior to making the case for applying lessons learned from military trauma 
management to the civilian sector, it is necessary to examine the similarities and 
differences between military and civilian trauma. Each system has characteristic 
patient populations, common mechanisms of injury, levels of care , prevention 
measures, and training of its prehospital providers. A brief overview of each 
system is provided below to facilitate the comparison between the two. 
In the military setting, patients are generally young, healthy, and 
physically-fit. Military healthcare providers also treat civilians and enemy 
combatants, but most of their patients are coalition troops. Since the dawn of 
armed conflict, traumatic injury and death have been issues faced by all militaries 
and this holds true today. Most battlefield injuries are due to penetrating trauma 
from gunshot wounds (GSWs) and explosions (Carr, 2004; Champion , Holcomb, 
& Young, 2009; Eastridge et al. , 2011 ; Kelly et al. , 2008). Due to the widespread 
use of improvised explosive devices (lEOs) by insurgents, the signature wound of 
our current conflicts (OEF and OIF) is traumatic brain injury (TBI) (Glasser, 
2011 ). However, hemorrhage has been , and remains , the greatest cause of 
potentially preventable combat death and has received much attention within the 
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military medicine community (Aiam, Burris, DaCorta, & Rhee, 2005; Eastridge et 
al. , 2011 ). 
When the military analyzes combat-related deaths to improve future 
mortality rates, it separates casualties into two groups, non-survivable and 
potentially survivable . This categorization is based upon expert review of 
medical records and autopsy data and is intentionally biased towards declaring 
wounds potentially survivable so as to improve military medical care as much as 
possible . US and coalition forces established the Joint Theater Trauma Registry 
(JTTR) to track combat casualties from OEF and OIF and centralize data 
collection for research and analysis. 
A JTTR review spanning data from October 2001 to June 2009 showed 
that 558 (4.6%) of the 12,235 documented battlefield casualties died after 
reaching a combat hospital. The primary mechanism of injury (MOl) responsible 
for death was noted for each casualty: explosion (72%), GSW (25%), motor 
vehicle collision (MVC) (2%), or other (1 %). 48.6% of decedents had non-
survivable wounds , while the remaining 51.4% had potentially survivable 
wounds. Non-survivable wounds were due to TBis or other central nervous 
system injury in 83% of cases, hemorrhage in 16%, and other causes like burns 
in the remaining 1% of cases. Potentially survivable wounds , however, were 
caused by uncontrolled hemorrhage (80%), TBI or central nervous system injury 
(9%), multiple organ failure (8%), and other causes (3%), such as loss of airway. 
Of the hemorrhage-related deaths, 48% were primarily torso wounds , 31% 
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extremity wounds, and 21% junctional wounds (groin , neck, axilla) (Eastridge et 
al., 2011 ). 
Modern military trauma care is delivered within a five-tiered system (Fox, 
Patel , & Clouse, 2011; Ling , Rhee, & Ecklund, 2010). The first three echelons of 
care are located within the theater of operations, and the final two are located in 
Europe and the United States. Level 1 care is provided on the battlefield by 
combat medics, fellow soldiers, and injured soldiers themselves or at a battalion 
aid station. Typical interventions at this level include tourniquets, hemostatic 
dressings, intravenous access, and emergency airway management. Level 2 
care is provided in a nearby facility that is analogous to a civilian emergency 
department. Oftentimes, Level 2 facilities have a forward surgical team (FST) . 
FSTs are composed of 20 medical personnel, including three general surgeons, 
an orthopedic surgeon , five nurses (two or more are also nurse anesthetists) , 
scrub technicians, eight combat medics, and a logistics officer (Starnes, Beekley, 
Sebesta , Andersen, & Rush, 2006) . FST surgeons remove tourniquets, explore 
wounds, and perform surgical procedures to control or definitively stop 
hemorrhage (Fox et al. , 2011 ). 
From there, casualties are evacuated to Level 3 facilities , known as 
combat support hospitals (CSHs). The equivalent of a civilian Level 1 trauma 
center, each CSH has 60 to 1 00 inpatient beds and is staffed with approximately 
300 personnel. Stationed at each CSH are 3-6 general surgeons, 2-4 orthopedic 
surgeons, 1-2 neurosurgeons, 1-3 oral-maxillo-facial surgeons, a cardiothoracic 
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surgeon, emergency medicine physicians, internal medicine physicians, 
radiologists , obstetrician/gynecologists, dentists, nurses, allied health workers , 
and support personnel. Combat support hospitals have advanced diagnostic 
imaging equipment, like CT scanners, and an extensive blood bank. In addition 
to stored blood products, CSH physicians routinely use fresh whole blood 
donated by volunteers (Starnes et al., 2006). More advanced surgical 
procedures, including definitive vascular repair and reconstruction whenever 
possible , are performed at Level 3 facilities (Fox et al., 2011 ). 
If casualties require further, or higher levels of, medical care, they are 
flown by Air Force medical teams to the Level 4 hospital, Landstuhl Regional 
Medical Center in Germany. Arrival at Landstuhl can be as soon as 12 hours 
after admission to a CSH. After further stabilization and treatment, American 
casualties are then flown to Level 5 hospitals, such as Walter Reed National 
Military Medical Center, for definitive surgical care and rehabilitation . Whereas it 
took an average of 45 days for an injured service member to be evacuated to the 
United States during the Vietnam War, it typically only takes an average of 8.5 
days today (Fox et al. , 2011; Ling et al., 201 0). With worldwide movement of 
casualties , military physicians conduct weekly, teleconferenced trauma rounds to 
coordinate patient care handoffs and share lessons learned (Kelly et al. , 2008). 
Prehospital trauma care in the military setting begins with prevention. 
Military tactics have evolved to keep pace with enemy tactics and weaponry. 
Since truncal hemorrhage is the leading cause of potentially preventable 
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battlefield death, body armor and vehicle armor have been critically important 
(Eastridge et al., 2011; Kelly et al., 2008). OEF and OIF have seen the largest 
number of amputees since the Civil War because body armor and advancements 
in medical care have allowed hundreds of soldiers and marines to survive injuries 
that would have certainly been fatal in previous conflicts (Glasser, 2011 ). 
Beyond prevention , all deployed soldiers and marines are issued first aid kits , 
sometimes containing hemostatic dressings, and tourniquets. In some way, all 
US and coalition troops are prepared to be first responders in the event of severe 
hemorrhage. 
The frontline providers of prehospital emergency military medicine are the 
Army combat medic and the Navy corpsman (assigned to Marine Corps units). 
They undergo a 16-week training program called the Tactical Combat Casualty 
Care (TCCC) course , which is roughly equivalent to the civilian EMT -Basic level. 
TCCC consists of hours of lecture, but focuses heavily on procedural skills, such 
as tourniquet use, intravenous and intraosseous access, hemostatic dressing 
application , and conventional hemorrhage control methods performed on 
anesthetized animals (Vance Y Sohn et al. , 2007). Combat medics and 
corpsmen are taught to modify their assessment and treatment algorithms based 
on the situation. "Care Under Fire", for example, necessitates tourniquet 
placement on all bleeding limbs to maximize hemorrhage control and minimize 
danger to medical personnel and troops alike. During "Tactical Field Care", 
those tourniquets are then re-evaluated to determine if limb bleeding can be 
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controlled with simpler methods. This phase is also when oral or IV fluids are 
administered, if indicated. Finally, "Casualty Evacuation Care" is provided en 
route to Level 2 or 3 facilities in vehicles or med-evac helicopters (Ling et al. , 
201 0). The hemostatic interventions and policies practiced by prehospital and in-
hospital military medical providers are presented and examined at length later in 
this thesis. There is also a level of prehospital trauma care in between that of 
each individual soldier and a combat medic. Each Army unit also has a number 
of combat lifesavers, who complete two weeks of medical training that includes 
learning how to establish IV access. 
In stark contrast to the relatively homogeneous demographics of the 
military patient population , civilian trauma patients are considerably more 
diverse. They span the range of neonates to geriatrics, are not necessarily in 
peak physical condition , and often have comorbidities such as vascular disease. 
The elderly can be particularly susceptible to hemorrhage as many frequently 
take anti-platelet and anticoagulant medications like aspirin , Plavix, heparin , and 
warfarin (Coumadin). Another significant difference is that unlike military trauma, 
where most injuries and deaths are due to penetrating trauma, civilian trauma is 
typically blunt trauma resulting from vehicular accidents and falls. This is not to 
suggest that trauma is any less of a concern in the civilian world ; on the contrary, 
the National Center for Injury Prevention and Control reports that unintentional 
trauma was the leading cause of death of all people aged 1 to 44 in the United 
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States between 1999 and 2007 ("CDC - Injury - WISQARS (Web-based Injury 
Statistics Query and Reporting System)," 2012) . 
In the mid-1990s, a review was conducted of all trauma deaths in the city 
of Denver and Denver County that occurred in 1992 (Sauaia et al. , 1995). One 
third of patients died prehospitally. The distribution of MOis is shown in Figure 1. 
At the time, the Denver area was plagued with drug-related violence, which is 
reflected in the high percentage of penetrating trauma deaths. However, motor 
vehicle accidents (including pedestrians and bicyclists struck by vehicles) still 
caused one third of all trauma deaths. Regardless of injury mechanism, 
exsanguination caused 39% of all traumatic deaths. This was similar to a 
previous finding that 35.5% of 897 traumatic deaths in Russia were due to 
uncontrolled hemorrhage (Tsybuliak & Pavlenko, 1975). 
BLUNT 
(48%) 
OTHER BLUNT (0 3%) 
AUTO/BICYCLE (1 % ) 
MCA (3%) 
ASSAULT (3%) 
AUTO/PED (7%) 
FALL (8%) 
MVA (26% ) 
BURN 
(2%) 
SW (6%) 
GSW (42%) 
OTHER PENETRATING (1%) 
PENETRATING 
(49%) 
Figure 1: Mechanisms of Injury in 1992 Trauma Deaths in Denver. Figure 
taken from Sauaia et al. , 1995. 
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A follow-up study was conducted of trauma deaths in the Denver area a 
decade later (Cothren, Moore, Hedegaard , & Meng, 2007). Years of anti-drug 
education and law enforcement efforts greatly reduced drug and gang-related 
violence. Motor vehicles were implicated in 43% of 2002 traumatic deaths, falls 
accounted for another 20%, and intentionally-inflicted trauma from GSWs and 
stabbings decreased to only 24% of trauma deaths. In total, 74% of deaths were 
due to blunt trauma, 24% to penetrating trauma, and 2% to burns. 
Another study reviewed over 75,000 trauma patients who presented to 
one of two Level 1 trauma centers in Houston, Texas between August 1994 and 
December 1999 (Dorlac et al. , 2005). Fourteen patients were identified who died 
of isolated penetrating limb trauma; half were injured by gunshot wounds and half 
were wounded by stabbing or other lacerations. Ten had severe arterial and 
venous injuries, three had only arterial injuries, and one had only venous injuries. 
86% of injuries were proximal to the knee or elbow, and 57% of the hemorrhage 
sites were determined to be amenable to tourniquet placement. This study did 
not include survivors of isolated penetrating limb trauma, those who died on-
scene, or those who died of other types of trauma. 
In most states, the civilian trauma system is based on four levels of 
service. Community hospitals may have an emergency department, but that 
does not mean they are designated trauma centers. A Level 3 trauma center is 
the next highest level of care , where surgical and intensive care services are 
available and most basic types of trauma can be handled . Level 2 trauma 
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centers have around-the-clock availability of physicians, surgeons, equipment, 
and personnel to manage severe trauma. Finally, Level 1 trauma centers have 
24-hour availability of all required personnel and resources, have active trauma 
research programs, host surgical residency programs, and see a high annual 
volume of trauma cases. A Level 2 military hospital is roughly analogous to a 
community hospital or Level 3 trauma center, and a Level 3, or combat support, 
hospital is comparable to a civilian Level 1 trauma center as previously 
mentioned . 
Trauma prevention in the civilian sector has a much broader scope. 
Vehicle-related injury and death are mitigated through driver training, seatbelt 
and airbag use, and public education about problems like drinking and driving. 
The Occupational Safety and Health Administration establishes and enforces 
safety codes to decrease the incidence of workplace injuries. Numerous 
programs also target violence related to drugs, gangs, and firearms. In addition 
to the variety of MOis in civilian trauma, preventative efforts have to address the 
wide range of age groups. 
Prehospital emergency medical care is typically performed by bystanders 
and public safety personnel. Police officers and firefighters in most areas are 
trained at the First Responder (advanced first aid) level at a minimum. The next 
level of care is typically the EMT-Basic, who is trained in non-invasive care of 
medical and trauma patients. EMT-Intermediates undergo more extensive 
train ing to learn intravenous access, advanced airway skills , and medication 
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administration in some states. The highest level of prehospital medical care is 
provided by the EMT -Paramedic, who receives extensive training in advanced 
airway management, cardiology, and pharmacological interventions. 
Despite their differences, military and civilian trauma care share key 
similarities. Both patient populations exhibit a tri-modal distribution of trauma-
related deaths: immediate deaths occur within minutes of injury due to 
devastating injuries that are generally not survivable; early deaths occur within 
hours due to head, lung , or abdominal injury; and late deaths occur within days 
or weeks or injury, usually due to lung, kidney, or liver failure (Nuland, 1995, pp. 
144-145). Half or more of all trauma deaths occur within hours, and usually 
within minutes, of trauma in both civilian and military settings (Cothren et al., 
2007; Eastridge et al. , 2011 ; NAEMT, 201 0; Sauaia et al. , 1995). The majority of 
hemorrhage-related deaths, in particular, occur within six hours and hemorrhage 
is the leading cause of preventable trauma death in both military and civilian 
settings (Aiam & Velmahos, 2011 ). Timely and effective prehospital 
interventions, especially those related to hemostasis , are therefore very 
important. 
Although they occur on different scales , the mechanisms of injury found in 
military and civilian trauma are comparable. The explosion injuries caused by 
lEOs are similar to the explosion injuries found in industrial accidents and 
terrorist attacks. In 2007 alone, 14,000 terrorist attacks caused 44,000 injuries 
and 22,000 deaths across the world , and the United States saw an average of 
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205 deaths per year in criminal bombing attacks between 2004 and 2006 
(Champion et al., 2009). Gunshot wounds occur less frequently in civilian 
settings, but they're more common in urban environments and high-risk law 
enforcement actions. Furthermore, rural areas are not immune to injuries 
resulting in severe hemorrhage, such as farming or hunting accidents, and they 
often have more remote access to emergency medical care (Lee, Porter, & 
Hodgetts, 2007) . Since uncontrolled hemorrhage is consistently a substantial 
source of military and civilian trauma deaths, it stands to reason that lessons 
learned about hemostasis in the high-patient volume, high-injury severity combat 
environment can be put to good use in the civilian world. 
Physiology of Hemostasis 
The human body has complex mechanisms that normally facilitate 
hemostasis. Immediately following injury to a blood vessel, smooth muscle in the 
vessel 's wall contracts , which narrows the lumen and slows blood flow. When 
large arteries and veins are transected , they also tend to retract into the body 
where surrounding tissue provides compression . Disruption of the smooth 
surface of the inner lining of the vessel wall , known as the tunica intima, causes 
turbulent blood flow. Circulating platelets change morphology, become sticky, 
release chemical mediators, and begin to aggregate. The most significant 
hemostatic event, however, is coagulation whereby circulating clotting factors are 
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activated and then generate fibrin, which traps red blood cells and forms strong 
clots (Bledsoe, Porter, & Cherry, 2008). 
The normal coagulation process is divided into three major phases: 
procoagulation , anti-coagulation , and fibrinolysis. During procoagulation , clotting 
factors interact with each other and other chemicals in a series of chemical 
reactions commonly called the clotting cascade. The major benefit of a cascade 
is that it rapidly accelerates the clotting process. One molecule can quickly 
activate many others, which can then each activate many others, and the 
reactions can therefore occur very quickly. Figure 2 illustrates the clotting 
cascade broken into three common divisions: the extrinsic pathway, the intrinsic 
pathway, and the common pathway. Ultimately, all pathways generate fibrin from 
the fibrinogen precursor molecules (Devlin , 201 0). 
The extrinsic pathway is triggered when damaged endothelial cells , which 
line the walls of the vasculature, expose tissue factor (also known as Clotting 
Factor Ill or Fill) to the circulating blood. Factor VII (FVII) binds to tissue factor 
and , in the presence of calcium ions, activates Factor X (FX). Activated Factor X 
(FXa) then proceeds to initiate the common pathway. Complexed with Factor V 
(FV), FXa then converts prothrombin to thrombin via proteolytic cleavage . 
Thrombin is vitally important in procoagulation because it modulates the rate of 
the clotting cascade , converts fibrinogen to fibrin , activates more clotting factors 
(FV, FVII , FVIII , and FXIII) , and plays a key role in platelet plug formation 
(Schreiber & Neveleff, 2011 ). 
13 
The intrinsic pathway is also triggered by damaged endothelium. Various 
anionic surfaces become exposed in endothelial cells, attracting Factor XII (FXII) . 
Electrostatic interactions cause a conformational change in FXII that makes it 
1,000 to 10,000 times more active. Prekallikrein and Factor XI (FXI), which are 
both complexed with high-molecular-weight kininogen in circulation , are also 
attracted to the newly-exposed anionic regions of damaged endothelium and 
come into contact with FXII, which then activates them to kallikrein and FXIa, 
respectively (Devlin , 201 0). 
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FXIa 
HMWf< 
TF-FVIIi FVIIa 
FX~FXa 
FV II ~a-FVI I I a 
FIXa 
FXI 
HMWK 
FXa-FV/FVa 
Prothrombin \ ./ ) Thrombin 
~ FVII FVIII 
FXIII 
FXIIa ~---- FXll 
Prekallikrein 
HMWK --~ Kallikrein HMWK 
Fibrinogen 
Hard clot 
Figure 2: The Clotting Cascade. Figure taken from Devlin , 2010. 
Kallikrein permanently activates FXII , accelerating the reactions of the 
intrinsic pathway. FXIa in turn activates Factor IX (FIX) , which complexes with 
activated Factor VIII from the common pathway. The FIXa-FVIIIa complex is 
able to activate FX thereby enhancing the common pathway and therefore 
thrombin and fibrin formation . Fibrinogen is a soluble molecule, but fibrin is not. 
Insoluble fibrin molecules associate to form a net around platelets and red blood 
15 
cells, forming a somewhat tenuous clot. Fortunately, activated Factor XIII from 
the common pathway forms crosslinks within the fibrin matrix, forming a more 
rigid , stable clot. While all of these clotting factors are performing their functions, 
thrombin also causes platelets to aggregate around the site of injury where they 
change shape and release important chemical mediators. Serotonin causes 
local vasoconstriction, von Willebrand Factor (vWF) strengthens interactions 
between platelets and endothelial cells, growth factor promotes tissue repair, 
Factor V serves as a critical cofactor for FXa, Protein C inhibitor prevents 
anticoagulation from starting too early, and ADP and thromboxane A2 promote 
autocatalytic platelet aggregation (Devlin, 201 0). 
As soon as injury occurs and procoagulation commences, the opposing 
reactions of anticoagulation also begin. Inhibiting molecules, when activated , 
bind strongly to the activated clotting factors and render them inert; these 
inhibitor-protease complexes do not tend to dissociate and they are cleared from 
circulation by the liver. Tissue Factor Pathway Inhibitor inhibits tissue factor-
FVIIa-Ca2+-FXa complexes on damaged endothelial surfaces. Antithrombin Ill 
inhibits thrombin , FXa , and other clotting cascade enzymes. FXa is also inhibited 
by Protein Z and Protein Z-dependent Inhibitor in the presence of calcium. In a 
key step also involving calcium, thrombin forms a complex with thrombomodulin 
in endothelial cell membranes. Within the thrombin-thrombomodulin-Ca2+ 
complex, thrombin has a highly decreased affinity for fibrinogen and a markedly 
increased affinity for Protein C, which it activates. When this occurs , thrombin 
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switches roles from promoting coagulation to halting it. Protein C, in conjunction 
with ProteinS, inactivates FVa and FVIIIa, effectively shutting down the intrinsic 
and common pathways (Devlin, 2010). 
Fibrinolysis occurs once adequate tissue repair has occurred and the fibrin 
clot is no longer needed. Plasminogen, another enzyme precursor, has a high 
affinity for fibrin and embeds itself within the clot. When it comes time to dissolve 
the clot, tissue plasminogen activator (t-PA) is released . t-PA also has a high 
affinity for fibrin and ends up distributed throughout the clot. When t-PA and 
plasminogen come into contact, plasmin is produced via proteolytic cleavage and 
converts the insoluble fibrin clot into soluble chunks that are then cleared by the 
liver. The t-PA molecules are then deactivated by type 1 and 2 plasminogen 
activator-inhibitors , and plasmin is similarly inhibited (Devlin , 201 0). 
Patients at risk of adverse thrombotic events like pulmonary emboli , heart 
attacks, strokes, and deep venous thrombosis often take medications that 
interfere with natural hemostatic mechanisms. Aspirin inhibits synthesis of 
thromboxanes and therefore platelet aggregation as well. Plavix (generic name 
clopidogrel) is another common oral antiplatelet agent. Many patients , especially 
those with atrial fibrillation , are prescribed a vitamin K analogue called Coumadin 
(generic name warfarin). Vitamin K is a required cofactor in the post-translational 
modification of prothrombin , Protein C, Protein S, FVII , FIX, and FX. Patients on 
Coumadin have incomplete versions of these proteins that cannot bind calcium 
or otherwise participate in the blood clotting cascade. Finally, many patients take 
17 
supplemental heparin. Heparin is a naturally occurring monosaccharide that 
forms polymers of various lengths that dramatically increase the inhibitory rates 
of antithrombin Ill molecules. In the presence of heparin, antithrombin Ill 
inactivates thrombin and FXa approximately 9,000 and 17,000 times faster, 
respectively (Devlin , 201 0). These patients, particularly the elderly, present 
unique challenges for hemorrhage control. 
Sometimes an injury's severity overwhelms the body's ability to quickly 
halt or minimize bleeding. Initially, the body's hemodynamic mechanisms adjust 
to the blood loss; this is known as compensated hemorrhagic shock. At some 
point, enough blood volume is lost that these mechanisms are no longer 
sufficient. In this uncompensated (or decompensated) shock, blood pressure 
plummets and the heart beats increasingly faster in an attempt to restore 
circulation. If hemorrhage continues, irreversible shock occurs where inadequate 
perfusion inflicts fatal damage to the body's organs. Once irreversible shock is 
reached , no interventions will prevent the patient from dying (Carr, 2004 ). 
To limit blood loss and stave off hemorrhagic shock, EMTs are taught to 
first apply dressings with manual pressure directly over the wound. Should that 
fail to control the hemorrhage, limbs are elevated above the level of the heart (as 
long as movement will not aggravate other injuries such as fractures) and indirect 
pressure is provided to the wound by manually compressing "pressure points". 
Elevating a limb lowers the blood pressure at the wound and theoretically makes 
it easier to facilitate bleeding cessation. Pressure points are simply locations of 
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major arteries proximal to the injury site; applying pressure is intended to 
physically reduce blood flow into damaged limbs. Hemostatic dressings are 
explained to EMTs as new products that may be considered if available . Finally, 
EMTs are instructed to use tourniquets for life-threatening limb hemorrhage that 
is unmanageable with the aforementioned methods and only as a last resort 
(Bledsoe et al., 2008). 
Decades ago, some physicians realized that patients with serious trauma 
received very inconsistent care, especially in rural areas. So, the Advanced 
Trauma Life Support program was developed to standardized hospital protocols 
for trauma management. Years later, an attempt at raising the quality and 
consistency of prehospital trauma care resulted in the creation of Prehospital 
Trauma Life Support (PHTLS). PHTLS teaches EMTs the pathophysiology of 
trauma and the most current evidenced-based trauma care principles and 
procedures, but it is not a required course for all EMTs (NAEMT, 201 0). Many of 
the recent updates to the curriculum are based upon the lessons from military 
trauma care presented within this thesis, but PHTLS is slow to adopt the more 
progressive changes suggested by combat medicine. 
Acute Coagulopathy of Trauma 
Traumatic hemorrhage causes numerous physiological derangements in 
the body that lead to coagulopathy, or degraded blood clotting ability. This acute 
coagulopathy of trauma (ACOT), sometimes called early trauma-associated 
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coagulopathy (TAC), is currently an area of active research. Coagulopathic 
bleeding is the leading cause of in-hospital trauma patient deaths, so a lot of 
attention is being given to understanding and treating the pathophysiology of 
ACOT (Rizoli et al., 2011 ). 
When circulating blood levels fall , blood vessels constrict and dilate 
throughout the body to shunt blood away from non-critical areas to ensure that 
the vital organs stay well-perfused. Wherever perfusion is inadequate, however, 
the decreased availability of oxygen forces cells to switch from aerobic to 
anaerobic metabolism, which produces lactic acid . Lactic acid builds up in the 
blood and lowers its pH. The clotting factors and other coagulation enzymes 
exhibit their highest rates of activity at a pH more basic than blood 's, so as the 
developing acidosis worsens, coagulation proceeds more and more slowly. For 
example, a drop in pH from 7.4 to 7.0 causes a 90% decrease in FVIIa activity, 
and 70% reductions in thrombin activation and FXa-FVa complex activity 
(Perkins , Cap, Weiss, Reid , & Bolan , 2008). One of the challenges of ACOT is 
that ischemic tissue may have a much lower local pH than the overall serum pH. 
The latter value can easily underestimate the degree of acidosis-mediated 
inhibition of coagulation at the injury site (Hoffman , 2004). 
Hypoperfusion creates several other significant problems for hemostasis. 
Endothelial cells are believed to produce and express more thrombomodulin in 
their cell membranes, which increases activation of Protein C, which then inhibits 
the extrinsic clotting pathway and promotes anticoagulation. The endothelial 
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cells are also triggered to release t-PA, prompting a hyperfibrinolytic state (Rizoli 
et al. , 2011 ). Moreover, continuous hemorrhage can exhaust the amount of 
circulating clotting factors, further impeding coagulation. Traditionally, it was 
believed that this decrease in clotting factor concentration was due to dilution of 
the blood by overly-aggressive fluid resuscitation with crystalloids like normal 
saline and lactated ringer's. However, it has been experimentally demonstrated 
that hemodilution by 40-60% is required to create measurable coagulopathy 
(Simmons et al., 2011 ). 
As hemorrhage progresses, hypothermia soon follows as shock inhibits 
the body's ability to regulate temperature (Perkins et al. , 2008). Hypothermia is 
sometimes used therapeutically following cardiac arrest or in other situations as a 
neuroprotective measure, but trauma-induced hypothermia does not provide that 
benefit. Instead, hypothermia following trauma further slows the coagulation 
reactions and significantly increases mortality rates. A study examined patients 
who were severely hypothermic (core temperature less than 32°C) upon hospital 
arrival and found that mortality rates were 23% overall and 100% in patients with 
trauma (Hoffman , 2004). 
There are a few common laboratory tests that evaluate a blood sample's 
coagulation ability. The extrinsic pathway's performance is measured by the 
prothrombin time (PT), where a sample of blood plasma is mixed with citrate to 
bind calcium and prevent clotting. Tissue factor is added, followed by an excess 
of calcium which allows the blood to clot again . This typically occurs in 10 to 12 
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seconds, but PT can vary by significant amounts depending on the laboratory 
procedure. So, the international normalized ratio (INR) standardizes prothrombin 
times for comparison . In general, coagulopathy is indicated by an INR greater 
than 1.5 in patients who are not on anticoagulants such as Coumadin . PT and 
INR measure deficiencies in Factors II, V, VII , and X as well as fibrinogen and 
other important enzymes (Rizoli et al., 2011 ). 
The intrinsic pathway is evaluated by activated partial thromboplastin time 
(aPTT), where a citrated plasma sample is again collected. Timing starts when 
phospholipid , a surface activator (like kaolin) , and calcium are added . It ends 
when a visible clot is formed ; typical values of aPTT are 30 to 45 seconds; a 
value in excess of 45 seconds is generally viewed as being indicative of 
coagulopathy in patients who are not on anticoagulants such as Heparin . aPTT 
can reveal deficiencies in Factors VIII , IX, XI , and XII as well as Factors V and X, 
fibrinogen , and prothrombin (Rizoli et al. , 2011 ). Another important test for 
coagulopathy is thromboelastography (TEG), which provides information about 
the speed of clot formation and the strength of the resultant clots. A shortcoming 
of laboratory tests, however, is that they are performed at 37°C. Blood samples 
from hypothermic trauma patients will therefore overestimate the coagulability of 
those patients (Perkins et al. , 2008). 
How common is ACOT? A study of 2,473 trauma patients showed that 
12% arrived at the hospital with coagulopathy or developed it within an hour, 
while an additional 11% developed coagulopathy within twenty four hours of 
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injury. Factors disposing trauma patients to ACOT/early TAC were acidosis, 
hypothermia, being male, severity of injury, pre-injury anemia, and large volumes 
of crystalloid administered prehospitally and in the emergency department 
(Engels et al. , 2011 ). Patients with TAC were more likely to require massive 
transfusion of blood products and were more likely to die from their injuries. 
Another study found that 20% of trauma patients arrived to a trauma center with 
one or more clinically-significant clotting factor deficiencies, defined as 30% of 
normal enzymatic activity or lower (Rizoli et al. , 2011 ). All of the patients were 
deficient in Factor V; 77% were only deficient in FV, 9% had two critically low 
clotting factors , 5% had three critically low clotting factors , and another 9% had 
deficiencies in eight clotting factors . Amongst these patients with severe clott ing 
factor deficiencies, 32% had elevated INRs, 36% had prolonged aPTTs, and 
35% had TEG values suggesting coagulopathy. In general , coagulopathy is 
associated with prolonged PT in 97% of cases, prolonged aPTT in 70%, and low 
platelet count in 72%. TEG is currently being evaluated as a front-line diagnostic 
test for assessing presence coagulopathy and determining an appropriate 
treatment (Perkins et al. , 2008). 
The preceding overviews of normal hemostasis and trauma-associated 
coagulopathy have introduced some of the physiologic challenges posed by 
severe hemorrhage. In the pages to follow, techniques and technologies for 
controlling bleeding in the combat setting are presented and discussed . Many of 
the improvements in survival rates from battlefield injuries have been made by 
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these advancements in prehospital and in-hospital trauma care. A basic 
understanding of hemostasis and the pathophysiology of coagulopathy will help 
the reader to understand how each of the combat hemostatic methods works. 
The efficacy of these interventions is evaluated along with the advantages and 
disadvantages of implementing them as standards of care in civilian prehospital 
trauma care. 
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TOURNIQUETS 
History 
A succinct and interesting history of medical applications of tourniquets 
was provided by Kragh et al. (Kragh Jr, Swan , Smith , Mabry, & Blackbourne, 
2011 ). Hindu medical texts dating from around the sixth century BC describe 
their earliest known use, which was for treatment of snakebites. It is believed 
that the Greeks learned about tourniquets from these texts as well. Early 
understanding of anatomy, physiology, and hemorrhage were quite rudimentary, 
so it is not too surprising that tourniquets were not used for control of bleeding 
until much later. In the third century BC, Erasistratus believed that arteries were 
naturally full of air and filled with blood only when injured. 
One of the earliest medical stances on tourniquet use for hemorrhage 
control highlights one of the longest-standing criticisms of their use. Galen , a 
roman surgeon who lived from 129-200 AD, was a staunch opponent of 
tourniquet use because he found them to increase bleeding . Likely, he was 
noting the effects of an improperly applied tourniquet. It is common medical 
knowledge today that an effective tourniquet must apply enough pressure to 
occlude both venous and arterial blood flow. A tourniquet that only occludes 
venous blood flow does in fact increase bleeding because it prevents blood from 
leaving extremities while allowing new blood to be continuously pumped in ; th is is 
precisely why phlebotomists and healthcare providers use venous-only 
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tourniquets when drawing blood or starting intravenous lines. Interestingly 
enough, the accepted medical knowledge of Galen's era was that venous blood 
and arterial blood originated from separate sources: the former from the liver and 
the latter from the heart. 
The first beneficial employments of tourniquets were not noted until many 
years later. In 1517, Hans von Gersdoff (a Prussian military physician) mentions 
tourniquet use in limb amputation surgeries. In 1593, the "Spanish windlass" was 
first described for use during amputations. It was not until 1628 that blood 
circulation was accurately explained by William Harvey. Shortly thereafter, in 
167 4, a French surgeon named Etienne Morel became the first person to 
definitively mention usage of tourniquets on the battlefield . The fate of the 
emergency tourniquet has been tied to data, or at least anecdotal evidence, from 
the battlefield ever since. Forty-four years later, the term "tourniquet" was coined 
by another French surgeon , Jean-Louis Petit, who named the device based on 
the turning motion used to tighten it. A final important event from the eighteenth 
century occurred in 1786 when Sir William Blizard recommended that ordinary 
sailors in the Royal Navy be trained in tourniquet use to provide a rapid initial 
response to severe limb hemorrhage. 
During the American Civil War, disagreement about the efficacy of 
tourniquets persisted . While a top Union surgeon , Samuel Gross, was a 
proponent of widespread tourniquet use, his Confederate counterpart, J. Julian 
Chisholm , described poor results of tourniquet use. Perhaps because of this 
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dismal view of battlefield tourniquets, the fate of the Confederate commander 
Albert Sidney Johnston was sealed . During the Battle of Shiloh in 1862, 
Johnston sustained a gunshot wound that resulted in a partially-transected 
popliteal artery. He gradually bled to death with an unused tourniquet in his 
pocket. 
Between the Civil War and World War I, new information came to light 
regard ing another pitfall of tourniquets, nerve damage. In 1873, Johannes 
Friedrich August von Esmarch reported that tightly-wrapped bandages (often 
composed of multiple layers and made of material that shrunk when exposed to 
water) could help to control bleeding as well. Early in the next decade, a German 
orthopedic surgeon described several cases of paralysis caused by Esmarch 
bandages and it became known that sustained high pressures led to nerve 
palsies. In 1904, Harvey Cushing developed a pneumatic tourniquet that allowed 
for monitoring of applied pressure via sphygmomanometer (like a blood pressure 
cuff) and a more equal distribution of pressure to the limb. 
World War I saw a continuation of the debate surrounding tourniquet use. 
The US military held a negative view of tourniquets . Navy corpsmen were not 
even issued them and an officer named Major Blackwood wrote that even though 
tourniquets could help to control severe bleeding , they were frequently overused 
and resulted in a large number of unnecessarily amputated limbs. Around this 
time, an Austrian trauma surgeon named Lorenz Bohler noted several failures 
regarding tourniquets. He reported that many times tourniquets were applied 
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before compression dressings or limb elevation were attempted, and 
unnecessary tourniquet use often resulted in limb ischemia, necrosis, 
amputation, and septicemia. He also reported that many times tourniquets were 
erroneously not used when basic hemorrhage control methods were insufficient. 
These observations aside, however, Bohler was an important proponent of 
tourniquets because he focused not on whether they should be used, but instead 
how and when they should be used. 
The conflicts of the twentieth century also resulted in differing opinions of 
tourniquet use. In 1936, the British Royal Air Force's senior orthopedic surgeon 
prohibited tourniquet use based on his analysis of anecdotal evidence from 
surgical procedures and since he was so well respected his views affected 
medical practice around the world. During World War II, the US Army analyzed 
two hundred randomly-selected cases involving tourniquet use and concluded 
that tourniquets were only sometimes capable of stopping arterial blood flow to a 
damaged limb and that tourniquets applied to thighs were particularly ineffective. 
The Korean War saw continued controversy regarding tourniquet use, but it was 
noted that hemorrhage control was crucial for saving lives and that tourniquets 
could play an important role. 
The turning point came from data collected the Vietnam War. Several 
studies reported that 7 to 7.4% of combat-related fatalities might have been 
prevented with better prehospital care, namely increased tourniquet use. 
Reports from the Israeli Defense Force have claimed good outcomes and low 
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complication rates from aggressive, early tourniquet use. Leading up to the 
current research and literature on battlefield tourniquet use, the US military noted 
after Operation Desert Storm in 1991 that uncontrolled limb hemorrhage 
remained a substantial source of preventable combat death. Just two years 
later, military healthcare providers recommended more frequent tourniquet use 
as a result of their experiences with the combat operations in Somalia during 
Operation Restore Hope. 
Current Literature 
The earliest of the relevant, contemporary literature on emergency 
tourniquet use comes from the Israeli Defense Force (IDF), which has 
encouraged liberal tourniquet use for several decades. In 2003, Lakstein et al. 
published a retrospective analysis of IDF tourniquet use from 1997-2001. During 
this period , 550 soldiers and civilians were treated from traumatic injuries due to 
direct combat action or terrorist attacks, including 91 patients who were treated 
with 110 tourniquets (Lakstein et al. , 2003). The tourniquets used by IDF 
personnel (200 em by 6.5 em elastic bands or improvised windlass tourniquets) 
differ from those used currently by US and coalition forces (commercially-
produced tourniquets), but the results of this study are still important to consider. 
The low threshold for tourniquet employment was readily evident; only 
53% of tourniquets were later deemed to have been indicated medically by the 
nature of the injury or tactically by the nature of the situation .(providing care 
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under fire , mass casualty incident, etc.). As the authors are quick to point out, 
however, although 125 (22%) of the 550 treated patients ultimately succumbed to 
their injuries, none of the deaths was attributed to uncontrolled extremity 
hemorrhage. One of the recommendations of the study was not surprisingly to 
focus on better training for medical personnel and lay-persons who were likely to 
use tourniquets. 
The data demonstrated that the morbidity and mortality associated with 
tourniquet usage were much lower than would have been predicted by 
conventional wisdom. The tourniquets were applied within fifteen minutes of 
injury in 88% of the cases. They remained in place, resulting in distal limb 
ischemia, for an average of 83 ± 52 minutes (range 1-305 minutes). Only seven 
limbs from five patients developed any neurologic complications (such as nerve 
palsies) . All of these sequelae occurred in conjunction with ischemic times in 
excess of 150 minutes, except for 109 minutes in one case. Another important 
recommendation from this study was that tourniquet times should be limited to a 
maximum of 1.5 to 3 hours. 
Lakstein et al. reported efficacy data that have been repeated ly validated 
by subsequent research. They found that only 78% of tourniquets were effective, 
and that better success was associated with application by medical versus non-
medical personnel as well as with anatomical location. While tourniquets were 
able to stop hemorrhage in 93% of upper extremities , they were only able to 
control hemorrhage in 71% of lower extremities (p < 0.01 ). A somewhat sobering 
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reality was that 68% of injuries requiring tourniquets were lower extremity injuries 
with 34% of injuries occurring in thighs. The difficulties associated with 
tourniquet efficacy in thigh applications will be discussed in greater depth 
throughout this section . 
The majority of the current literature on emergency tourniquet use has 
been published since the US launches of Operations Enduring Freedom and 
Iraqi Freedom (OEF and OIF, respectively). In 2003, a panel of military 
physicians, combat medics, researchers, and biomedical engineers was 
convened at the Advanced Technology Applications for Combat Casualty Care 
Conference to discuss the major issues surrounding combat tourniquet use 
(Walters & Mabry, 2005). They made several important determinations and 
recommendations upon which further research and policy have been based. 
One of the first issues they addressed was what exactly constituted an 
appropriate tourniquet for combat use. To prevent increased hemorrhage, it 
must be capable of occluding both arterial and venous blood flow to limbs. 
However, it was noted that effective tourniquet placement might still result in 
oozing from medullary bone bleeding . They discussed how difficult it was to 
control hemorrhage in legs and reached a consensus opinion that the narrow 
"strap and buckle" and "one-handed" tourniquets in common circulation at the 
time were ineffective and likely the proximal cause of this problem . 
At the root of this problem is the inverse relationship between the 
circumference of a limb and the pressure required to occlude arterial blood flow 
31 
within it, as shown in Figure 3. The panel quoted a typical range of arm 
circumferences of male soldiers to be 11.5-15.0 inches and a typical range of 
thigh circumferences of male soldiers to be 20.3-26.7 inches. When the ratio of 
tourniquet width to limb circumference was plotted for a one-inch tourniquet with 
a large and a small thigh, it became obvious that the required occlusion pressure 
would be infinitely high. 
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Figure 3: Effect of Tourniquet Width to Limb Circumference Ratio on 
Required Occlusion Pressure. Figure taken from Walters & Mabry, 2005. 
The natural conclusion was that wider tourniquets are better; they more 
evenly distribute pressure to limbs and require less overall pressure to 
completely occlude blood flow to a limb. The panel experts also noted , however, 
that wide tourniquets tend to buckle and apply more pressure at the center of the 
band than at the edges. The need to identify tourniquets of adequate width was 
a recommendation of the panel because 68% of combat-related limb injuries 
amenable to tourniquets occurred in lower extremities (Lakstein et al. , 2003) . 
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Two additional recommendations concerned training and limb cooling. 
The panel suggested that both didactic and hands-on training should increase for 
medics, combat lifesavers (soldiers given additional training in combat first aid), 
and soldiers going to infantry or noncommissioned officer schools. This training 
would focus on reviewing indications and contraindications for tourniquet use as 
well as discussing how and when to loosen or remove tourniquets. Finally, the 
panel reported research suggesting that cooling of ischemic limbs by as little as 
2-3·c might significantly reduce tissue damage. 
Other important instructions regarding tourniquet use come from decades 
of experience in civilian operating rooms. Surgeons have long used pneumatic 
tourniquets to produce and maintain stable, bloodless fields for procedures with 
great success. Air Force Colonel (Dr.) David Welling summarized some of those 
instructions. Wider tourniquets are preferable and are typically applied on the 
proximal third of arms and legs, at the point of maximum circumference , to avoid 
damaging sensitive neurovascular bundles. Pneumatic tourniquets allow for a 
careful monitoring of cuff pressure, which he states typically need not exceed the 
patient's systolic blood pressure by more than 30-70 mmHg. The paper 
recommends optimal cuff times of one hour for arms and just over one hour for 
legs (Welling , Burris, Hutton , Minken , & Rich , 2006). 
To collect demographic, clinical , and outcome data gathered from the 
treatment of trauma patients in military hospitals during OEF and OIF, the Joint 
Theater Trauma Registry w;:~s created . Recent analysis of combat tourniquet 
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efficacy has mostly come from either prospective studies conducted at one or 
several locations or retrospective studies of data extracted from the JTTR 
database. Great strides have been made in both the quality and quantity of 
JTTR and local medical data, but early records were often incomplete while the 
new systems experienced growing pains. 
One of these early studies was a retrospective analysis of all trauma 
patients who presented to the 31st Combat Support Hospital (CSH) in Iraq 
between January 1 and December 31 , 2004. During this time period , tourniquets 
had been widely issued and distributed to troops and medical personnel alike , 
but the push for increased tourniquet use had not yet been made. Of the 3,444 
trauma patients treated at 31st CSH, 165 were included in the study because of 
tourniquet use, traumatic amputations excluding some partial amputations 
(hands, feet, fingers , or toes), and/or damage to named vessels (Beekley et al. , 
2008). 
The 165 patients who met the inclusion criteria were separated into two 
groups: 67 patients who received a total of 80 tourniquets, and 98 patients who 
did not receive a tourniquet. Between the two groups, the only significant 
differences were slightly older average age (28 .5 versus 25) , slightly higher limb 
Acute Injury Score (4.4 ± 0.2 versus 4.0 ± 0.2) in patients with extreme injuries 
(ISS> 15), and a lower percentage of injuries occurring in upper arms (16% 
versus 30%) in the tourniquet group. There were no statistically significant 
differences in gender, nationality, mechanism of injury (explosion v. gunshot 
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wound v. motor vehicle collision), mortality, physiologic parameters on initial 
presentation (blood pressures, heart rate, temperature, hematocrit, blood pH , 
and base deficit), or average amount of blood products used during resuscitation 
(packed red blood cells, fresh whole blood, fresh frozen plasma, or 
cryoprecipitate). 
When it came to effectiveness of tourniquets, however, there were a 
number of statistically significant findings. Patients with tourniquets arrived to the 
CSH with their limb hemorrhage under control 83.3% of the time, while patients 
without tourniquets arrived with controlled extremity bleeding in only 60.7% of 
cases (p = 0.033). In patients with severe injuries (ISS > 15), those numbers 
were 85% and 17% (p < 0.0001 ). Tourniquets can clearly make a large 
difference in controlling hemorrhage from extremity injuries and they become 
more efficacious as the severity of the injury increases. 
61% of tourniquets had documented prehospital placement times; on 
average, they were in place for 70 minutes (range 5-120 minutes). There were 
no significant differences in mortality (4.4% v. 4.1 %) or post-admission limb 
amputations (6% v. 9%) between the tourniquet and non-tourniquet groups. 
Actually, no complications or late neurological sequelae were found to be 
attributable directly or solely to tourniquet use. As the authors point out, the 
relatively short limb ischemia times were likely the reason for this finding . 
Several problems with tourniquet effectiveness were noted . 52 
tourniquets (applied to 42 patients) had effectiveness data documented ; of these, 
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15% were determined to be ineffective upon arrival to the CSH . Anatomically, 
four of these were located on thighs, two on lower legs, and two on forearms. 
Furthermore, 11 thigh tourniquets were found to have initially controlled 
hemorrhage but failed to prevent re-bleeding once fluid resuscitation was begun. 
These data illustrate once again the challenges in controlling hemorrhage from 
thigh injuries. A single tourniquet was placed distal to the actual injury, and 18% 
of tourniquets were placed on limbs without a medically-indicated injury. These 
placements were speculated to be due to deficiencies in training or the result of 
providing care under hostile fire . 
"Errors" in tourniquet use were also identified in other studies. For 
example, six patients with eight applied tourniquets were brought to Kandahar Air 
Base in Afghanistan between February and May 2006. It was determined that 
four of the patients had their lives saved by five appropriately- and properly-
applied tourniquets . However, one patient had a venous-only tourniquet (a 
"misuse") and another had two tourniquets that were applied for over four hours 
(an "overuse") although notably without any long-term complications as a result 
(Tien , Jung , Rizoli , Acharya , & MacDonald , 2008). 
The limitations of the Beekly et al. study are important to consider. Due to 
problems with medical record keeping practices of 2004 , tourniquet placement 
times were unknown in nearly two out of five cases . Also troublesome was that 
only 28% of the patients in the non-tourniquet group had documentation as to 
whether their bleeding was controlled upon arrival to the CSH. In determining 
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complications of tourniquet use, only 52% of treated US casualties had follow-up 
data collected. The outcomes of nearly half of the treated soldiers were therefore 
unknown, which makes it difficult to confidently draw conclusions from the 
presented data. Furthermore, follow-up data was collected an average of 47 
days after injury for US personnel while that for non-US casualties was collected 
only 1 0 days later, on average, as they were discharged from the US military 
medical system to Iraqi hospitals upon being appropriately stabilized. 
Despite the shortcomings of this study, it clearly supported tourniquet use 
for control of extremity hemorrhage and strongly suggested that complication 
rates may be low, especially when tourniquets are not left in place for long 
periods of time. The authors commented that the US Army Institute of Surgical 
Research had recommended three tourniquets: the Combat Appl ication 
Tourniquet (CAT), the Emergency Medical Tourniquet (EMT) , and the Special 
Operations Forces Tactical Tourniquet (SOFTT) and that the US Army Surgeon 
General recommended in 2005 that all soldiers carry tourniquets on their persons 
while in combat zones. They also proceed to recommend that "civilian 
prehospital providers should consider the portable pneumatic tourniquets as a 
first-line treatment for life-threatening extremity hemorrhage", referring to devices 
like the EMT (Beekley et al. , 2008). It is interesting to note that although 
pneumatic tourniquets have been used successfully in civilian operating rooms 
for decades with few complications , they are just now being employed as 
emergency tourniquets (Graham, Breault, McEwen, & McGraw, 1993; Nitz & 
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Matulionis, 1982; Pedowitz et al., 1991; Wakai, Winter, Street, & Redmond , 
2001 ). 
US Army Colonel (Dr.) John F. Kragh has been a driving force in the 
evaluation of combat tourniquet effectiveness. In addition to authoring several 
historical articles and literature reviews, COL Kragh and his colleagues have 
published two large-scale studies (one a continuation of a previous one) based 
on data collected at the 1Oth and 28th CSHs in Iraq. As a result of much larger 
sample sizes, they have been able to draw more valid conclusions about the 
efficacy of, and complications associated with, emergency tourniquet use. 
Conducted between March 19 and October 4, 2006, their first study 
analyzed 428 tourniquets applied to 309 extremities in 232 patients (Kragh et al. , 
2008). Some were applied prehospitally, others were applied at the CSH , and 
one was applied in an I CU. The tourniquet type/brand was noted in nearly all 
cases ; efficacy data are presented in Table 1. The two most commonly used 
tourniquets were the CAT and the EMT. By this time, CATs had been issued to 
all deployed soldiers and marines and EMTs were generally available only in 
hospitals and evacuation vehicles. The data presented in the table are from the 
most commonly used tourniquets; several others were used only a handful of 
times and have been omitted. When presented in descending order of tourniquet 
effectiveness , several trends emerge. In this order, the width of the devices also 
decreases. Yet again , it is readily apparent that wider tourniquets are generally 
more effective. Furthermore, wider tourniquets are associated with fewer 
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morbidities and less need for back-up, which was defined by the authors as the 
need to apply additional tourniquets when the first tourniquet was not able to 
control hemorrhage by itself. A single tourniquet was able to effect bleeding 
cessation 82% of the time, while two or more tourniquets accomplished that in 
92% of cases. The data also clearly demonstrate that the commercially-
developed and rigorously-tested tourniquets selected by the US Army are 
significantly more effective than improvised tourniquets, which are still fashioned 
by troops in combat as they have been for centuries. 
Table 1: Tourniquet Efficacy and Morbidity by Product. Data adapted from 
K h t I 2008 ragl e a. , 
Type Patients Devices Limbs Effective Morbidity Back-Up 
EMT 91 115 115 92% 8% 0% 
CAT 156 210 202 79% 21% 5% 
SOFTT 50 62 61 66% 33% 2% 
Improvised 15 16 15 25% 80% 17% 
As in previous studies, tourniquet effectiveness was variable by 
anatomical location. It was easiest to control hemorrhage in lower legs (100%) 
followed by forearms (92%), upper arms (81 %), and thighs (73%). Despite the 
difficulties with larger circumference limbs, tourniquets themselves did not appear 
to cause permanent injuries or increase mortality. Four patients developed 
transient nerve palsies at the level of the tourniquet, and six more developed 
transient nerve palsies at the level of the wound. The palsies in that second 
group were believed to be a byproduct of the injuries and not the tourniquets. 
The authors reported that no subsequent amputations were due to tourniquet use 
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and that there was no association between how long tourniquets were in place 
and downstream morbidities, including blood clots, muscle death, rigor, 
fasciotomy, renal failure , or pain (Kragh et al. , 2008). 
Tourniquet use was strongly associated with decreased mortality, as 
shown in Figure 4. Patients who received one or more tourniquets to control 
their extremity hemorrhage were 92% more likely to survive than those who did 
not. When tourniquets were applied in the field , patients were 13% more likely to 
survive as compared to patients who received tourniquets upon arrival to a 
hospital. Of the 194 patients who received prehospital tourniquets, 11% later 
died from their injuries as opposed to 24% of the 38 patients who received their 
tourniquets at a hospital. When patients received tourniquets before 
demonstrating signs of shock (absence of palpable radial pulses and/or acute 
confusion), they were 80% more likely to survive. Overall mortality rates were 
14% of those (31 patients) who received tourniquets, 0% who received 
tourniquets despite the lack of a medical or tactical indication for one, and 100% 
of those (5 patients) who had severe limb hemorrhage but did not receive a 
tourniquet (Kragh et al. , 2009). 
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Figure 4: Increase in Survival with Tourniquet Use. Figure taken from Kragh 
et al. , 2009. 
COL Kragh and his colleagues made several conclusions relevant to 
prehospital tourniquet use as a result of their findings. First of all , as suggested 
by previous analyses of combat tourniquets, there does not appear to be a 
substantial risk of increased morbidity due to short-term tourniquet use. They 
promote increased survival when applied prehospitally, and they substantially 
decrease mortality when applied before the onset of shock. The data also 
demonstrate that tourniquets should be applied prior to patient extrication and 
transportation. In all of these situations, tourniquets are more effective the earlier 
they are applied during patient care. It was also directly stated that tourniquets 
could be an important tool in the civilian sector for management of mass casualty 
incidents (MCis) where the number of patients may initially overwhelm the 
resources of first responders . The emphasis placed on increased training and 
education about tourniquet use was also noted to be paying off; in contrast to 
previous studies, 97% of tourniquets were both placed correctly and medically or 
tactically indicated (Kragh et al. , 2008, 2009). 
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Since the results of that study were so enlightening, it was continued for 
another sixth months. Although the two sixth-month study periods were 
overseen by different site investigators and medical providers, the data were so 
statistically similar that they could be pooled for analysis. The patients were men 
and women of thirteen different nationalities, including sixteen children and five 
elderly persons. There were a total of 499 patients, 232 from the aforementioned 
study and 267 additional ones from the second study period. In all , 862 
tourniquets were applied to 651 limbs. 328 were left-sided tourniquets and 323 
were right-sided ; 176 were applied to upper extremities whereas 475 were 
applied to lower extremities. Both studies revealed an 87% survival rate from 
limb hemorrhage with tourniquet use, similar rates of transient nerve palsy 
secondary to a tourniquet (1.7% v. 1.5%), and identical rates of major limb 
shortening after hospital arrival (0.4%) (Kragh Jr et al. , 2009). 
The data from this study strongly reinforce some of the ideas presented 
earlier in this paper. Some limbs, especially those with large circumferences , 
present great difficulties in controlling hemorrhage. Bleeding was controlled with 
one tourniquet in 455 limbs, two tourniquets in 166 limbs, three tourniquets in 24 
limbs, four tourniquets in three limbs, and five tourniquets in one limb. Most of 
the injuries requiring multiple tourniquets involved narrower tourniquets , such as 
the CAT and SOFTT. The importance of early tourniquet placement was also 
highlighted ; 96% of survivors received their tourniquet before the onset of shock 
whereas only 4% of survivors got theirs after developing clinical signs of shock (p 
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< 0.001 ). Tourniquets are not able to reverse shock, but they are quite effective 
at holding it off. Regardless of presence or absence of shock, 89% of patients 
with prehospital tourniquet placement survived compared to 78% of patients with 
hospital tourniquet application (p = 0.015). Even amongst those treated in the 
field , patients who got tourniquets after extrication from vehicles or tactical 
situations developed more morbidities than those who received tourniquets within 
moments following injury. For 15 patients, there were 16 tourniquets placed 
without indication. Of these, most were wounds with more conventionally-
controlled bleeding and one was a tourniquet placed on the incorrect (an 
uninjured) limb. However, there were no complications from these improper 
uses. 
Valuable perspectives on combat tourniquet use have also been provided 
by the United Kingdom (UK). Brodie et al. reviewed the records of 1,375 
casualties from the JTTR database who presented to UK military hospitals 
between February 4 , 2003 and September 30 , 2007. 107 tourniquets had been 
applied to the 70 patients who met inclusion criteria for the study. They were 
categorized by the primary clinical indication for tourniquet use: open fractures 
(25/70), traumatic amputations (25/70), soft tissue injuries (15/70), and arterial 
injuries (5/1 0). Geographically, 106 tourniquets were applied prehospitally, with 
three removed prehospitally after reassessment; the remaining one was applied 
at the emergency department where eleven more tourniquets were removed after 
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reassessment. Ultimately, 87% of tourniquet patients survived (Brodie et al. , 
2007). 
The complication rate was higher than in previous studies. One patient 
developed ulnar nerve palsy from a tourniquet placed under fire . Two leg 
tourniquets caused compartment syndrome requiring surgical intervention . In 
one of those cases, a thigh tourniquet was applied over a pocket containing a 
small book. It is believed that this resulted in a venous-only tourniquet effect. 
However, the time period of this study included earlier segments of OEF and OIF 
when tourniquet training was not as thorough or standardized as it later became. 
It is unknown, based on the study's reporting , when these complications 
occurred , what type of tourniquet was used , whether they had been properly 
applied , or how long they were in place before the complications developed. 
Some of the patients in this study received additional hemostatic 
measures in addition to their tourniquets. After the release of QuikCiot in April 
2005, three patients had it applied to their wounds, as did ten patients who 
received HemCon after its release in April 2006. Seven patients who presented 
with severe coagulopathy were given recombinant clotting factor VIla after being 
given tourniquets, and all seven survived . It is unclear whether these patients 
would have survived with tourniquet use alone or how these hemostatic adjuncts 
may have otherwise impacted the results of this study. Hemostatic dressings, 
like QuikCiot and HemCon, and pharmacological interventions, such as 
recombinant factor VIla , are discussed at length in later sections. 
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Another study conducted by the UK military specifically examined 
complications of combat tourniquet use. The authors compared two sets of 22 
patients who either received , or did not receive, tourniquets for severe extremity 
injuries. The casualties had comparable mangled extremity severity scores 
(median of 5, the threshold for amputation) and injury severity scores (median of 
15, corresponding to substantial injury). While there were no statistically 
significant differences in complication rates (p = 0.13), superficial wound 
infections (p = NS), amputations later required (p = NS), or subsequent surgical 
flap failures (p = NS), the patients who received tourniquets were more likely to 
have deep tissue infections (p < 0.05), usually osteomyelitis. The authors 
concluded that this was because combat wounds are generally quite 
contaminated and patients who got tourniquets were more likely to have suffered 
from deeply-penetrating gunshot wounds while those who did not receive 
tourniquets were more likely to have sustained injuries from an explosion. They 
also concluded that tourniquet times should be limited to two hours to minimize 
complications (Clasper, Brown , & Hill , 2009). 
As a result of many years of successful combat tourniquet use, the UK 
military has adopted several fundamental procedures regard ing tourniquet use. 
In place of the long-standing Airway, Breathing, Circulation (ABC) initial trauma 
treatment model , the current practice is to employ a CABC model , where the 
previous three are preceded by control of life-threatening hemorrhage (Niven & 
Castle , 201 0). Simply put, the highest priori ty in treating a trauma victim is to 
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ensure that he or she will not exsanguinate while other critical interventions are 
being performed; severe hemorrhage must be arrested as early as possible. 
Extrapolation from the lessons learned by the UK military has led to 
several recommendations for potential civilian, prehospital tourniquet use (Niven 
& Castle, 201 0). Tourniquets should ideally be brightly colored to preclude their 
being overlooked, and they should only be applied for a maximum of 90 to 120 
minutes whenever possible. To minimize tourniquet times, patients arriving to 
hospital emergency departments should be given the highest triage priority. In 
addition, EMS providers should be trained to loosen tourniquets to re-evaluate 
their need, but tourniquets should never be loosened on patients who are in 
shock or who have known or suspected uncontrollable bleeding. 
In 2009, Swan et al. proposed four unanswered questions about 
tourniquet use: which was the simplest one, if they can be used successfully 
below the elbow and knee, if pain is a significant factor, and what evidence 
supports the use of pressure points (Swan, Wright, Barbagiovanni, Swan, & 
Swan, 2009). They found that while sphygmomanometers (blood pressure 
cuffs) , CATs, rubber tubing (as used by the IDF), and improvised Spanish 
windlass tourniquets are all effective at eliminating arterial blood flow (cessation 
of distal pulses by ultrasound) in most cases, the windlass tourniquets were the 
easiest to apply. The sphygmomanometer worked perfectly in all but two 
applications where it was not large enough to fit around the test subjects' thighs. 
Several tests of the rubber tubing and windlass tourniquets on lower legs and 
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thighs had to be discontinued due to extreme pain. The authors offered that pain 
is an irrelevant symptom when loss of life or limb is imminent. 
After conducting the tourniquet trials, the ten subjects in the study had 
manual pressure applied to several pressure points to determine if arterial blood 
flow could be occluded, as is taught in first aid and prehospital emergency 
medical training . The brachial artery was selected to occlude upper arm and 
forearm blood flow, the femoral artery was used for thigh blood flow, and the 
popliteal artery was chosen for lower leg blood flow. Once again , using Doppler 
(ultrasound) the investigators determined if there was any blood flow to each of 
the extremities while the pressure points were being manually compressed. 
Pressure points were successful at occluding arterial blood flow 90% of the time 
in upper arms, 60% of the time in forearms, 90% of the time in thighs, and 60% 
of the time in lower legs. What shocked the investigators, however, was that in 
nearly every one of these successful cases, blood flow returned to the limb in 
question within one minute (and in some cases, less than ten seconds). This 
finding was attributed to a combination of rescuer fatigue and collateral 
circulation in the limbs allowing restoration of perfusion. 
After many years of collecting data and evaluating combat tourniquet 
efficacy, some new conclusions have been reached. Taylor et al. note that lEOs 
are constantly becoming more sophisticated and more powerful , resulting in 
increasingly proximal and severe limb injuries. Because of this new reality and 
reports of patients arriving to CSHs with persistent bleeding with mid-thigh 
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tourniquets in place, they re-tested the efficacy of CATs and EMTs. Twenty-four 
volunteers were asked to apply a mid-thigh CAT to one leg and blood flow was 
assessed with ultrasound. Then, a CAT was applied to a volunteer's opposite 
leg by a researcher and distal blood flow was assessed. Finally, each volunteer 
received an EMT and distal blood flow analysis . Once again , anecdotal evidence 
about difficulty with mid-thigh tourniquets was confirmed with data. Self-appl ied 
CATs were effective 16.6% of the time and researcher-applied CATs were 8.3% 
effective, while mid-thigh EMTs were 75% successful at occluding distal pulses 
(Taylor, Vater, & Parker, 2011 ). 
At Camp Bastion in Afghanistan, EMTs are noted to be the most effective 
tourniquets for mid-thigh application and they are frequently exchanged with 
CATs upon patient arrival from the field. While both the CAT and EMT are 
compact and lightweight, the CAT is a better suited for combat operations. 
Although it is the narrower of the two (40 mm v. 90 mm), the CAT is much more 
durable and can be self-applied by injured casualties. In contrast, the EMT is a 
superior tourniquet for hospital use; it is wider, it can deliver sustained pressures 
of up to 300 mmHg, and it is far more effective at maintaining hemorrhage control 
once aggressive fluid resuscitation begins and blood pressures rise (Taylor et al. , 
2011 ). 
Another set of new insights has been provided by Kragh et al. Because of 
aggressive combat tourniquet use, death from isolated limb hemorrhage is no 
longer the leading cause of preventable combat death . That dubious honor now 
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belongs to junctional hemorrhage that occurs most commonly in the groin but 
also the shoulder girdle, base of the neck, buttocks, gluteal and pelvic areas, 
perineum, and axilla. These locations may be amenable to truncal tourniquet 
applications, but thus far there is only one truncal tourniquet that has been FDA 
approved (the Combat Ready Clamp) and there are insufficient data to evaluate 
its efficacy (Kragh et al., 2011 ). 
In the years to come, military medicine will surely continue to make 
advancements in the field of junctional hemorrhage control and these 
advancements will likely have implications for civilian trauma care. There are 
some promising investigations into the use of abdominal pressure points to 
control junctional hemorrhage, but much more research needs to be done. 
Researchers at the Medical College of Georgia determined that 80-140 pounds 
of pressure applied over the umbilicus by a knee or fist should occlude the distal 
abdominal aorta , but study participants could not tolerate more than 80 pounds. 
They also found that the pain from 120 pounds of force directly over the proximal 
right iliac artery was tolerable and that it was a sufficient amount of force to 
prevent blood flow to the right common femoral artery {Biaivas, Shiver, Lyon , & 
Adhikari , 2006). Regardless , it remains to be seen whether abdominal pressure 
points and truncal tourniquets will find a place in military and civil ian trauma care . 
Stemming from their review of combat hemorrhage management, Lee et 
al. have offered several suggestions regarding emergency tourniquet use in the 
civilian sector (Lee et al. , 2007). Their hemostasis algorithm for extremities is 
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presented in Figure 5. Each step is designed to control limb hemorrhage with the 
simplest and least risky interventions first. In accordance with longstanding first 
aid dogma, they believe the first step should be to apply direct pressure to the 
wound and elevate it above the heart if necessary. These two actions will stop 
the majority of limb hemorrhage. For deeper wounds, packing with gauze may 
also be necessary. A windlass dressing, identical to a windlass tourniquet except 
for placement and magnitude of force applied, can then be applied to provide 
continuous, direct pressure to the wound. 
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Figure 5: Proposed Limb Hemorrhage Control Algorithm. Figure taken from 
Lee et al. , 2007. 
Although clearly discouraged by Swan et al. , the next proposed step is to 
apply indirect pressure via pressure points for persistent limb hemorrhage. At 
any point in this process, they also recommend appropriate use of hemostatic 
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dressings, which are discussed in the next section. Despite all of the data 
surrounding combat tourniquet use, Lee et al. still recommend them only as a. 
last resort for refractory hemorrhage that has not been controlled by all of the 
preceding methods. 
Beyond this hemorrhage control algorithm, they made a number of other 
recommendations for civilian tourniquet use (Lee et al., 2007). Commercial 
tourniquets are preferable to improvised ones, an oft-noted sentiment in 
contemporary tourniquet literature. Tourniquets should be placed as distally as 
possible, but at least five centimeters proximal to the wound. If additional 
tourniquets are needed , they should be placed immediately proximal to the 
previous ones. Tourniquet placement time should be noted and while tourniquet 
time should be limited, significant tissue ischemia is unlikely to develop in less 
than an hour. As in previous literature, they also wonder if prehospital limb 
cooling can minimize tourniquet-related ischemic injury. 
Recommendations 
From the recent experiences of US, UK, and Israeli military forces , it has 
become clear that emergency tourniquets are an easy, effective way to control 
life-threatening limb hemorrhage with minor risk of complications. Historically, 
tourniquet use has been associated with unnecessary loss of limb, nerve and 
soft-tissue damage, and often inability to consistently control bleeding . Many of 
these problems are directly attributable to inadequate tourniquet designs, 
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excessively long application times, and deficient training of prehospital providers. 
The recent advancements in tourniquet technology and procedures offer 
solutions for each of these problems. 
In any EMS system that wishes to employ tourniquets, only proven and 
effective devices should be considered. Although some situations such as 
wilderness accidents may necessitate the use of an improvised tourniquet, a 
professional EMS agency should not rely on that strategy. Many of the 
commercially-prepared tourniquets currently found on ambulances and in first aid 
kits are very narrow and rely on primitive mechanisms such as Velcro ; they are 
very unlikely to be effective, especially in large-circumference limbs. In a worst-
case scenario, they will merely occlude venous blood flow and actually increase 
hemorrhage. 
Emergency tourniquets should be at least one inch wide , but preferably 
wider. Several well-proven devices are now available, such as the CAT and the 
EMT. The major benefits of a pneumatic tourniquet like the EMT are that it 
requires less overall pressure, it more evenly distributes that pressure to the limb, 
and the pressure can be closely monitored via the attached pressure gauge . 
Swan et al. showed that stock blood pressure cuffs , which are required 
equipment for every ambulance, are very effective tourniquets when the cuff is 
large enough to fit around the limb in question . Dr. Paul E. Pepe, responding to 
one of COL Kragh 's papers (Kragh et al. , 2008), suggested that pneumatic 
tourniquets could be modified to include an electronic device that measures 
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inflation times and pressures. In this case, there would be no ambiguity as to 
how long the tourniquet had been on or the amount of pressure applied over 
time. Preferably, tourniquets would also be brightly colored to reduce the 
chances that an in-place tourniquet is not overlooked or forgotten. 
Having secured appropriate and durable tourniquets , it is then critical to 
reassess the indications for emergency, prehospital tourniquet use. Obviously, 
they should be highly encouraged in cases of severe extremity hemorrhage. 
However, instead of erring towards avoidance of tourniquets, prehospital 
providers should be encouraged to apply a tourniquet when it doubt. As Swan et 
al. demonstrated , pressure points are not effective interventions for stopping limb 
hemorrhage, and they prevent rescuers from performing any other assessment 
or patient care. With modern tourniquets and typically short transport times to 
hospitals , the risks associated with short-term tourniquet use are very small. 
Nerve palsies, the most frequent complication , are usually transient and lasting 
deficits are rare. Allowing a trauma victim to exsanguinate is clearly the greater 
of the two risks. In cases of motor vehicle collisions (MVCs) with severe limb 
hemorrhage, the lessons from the battlefield have taught us that tourn iquets 
should be applied as soon as possible. Whenever these limbs are accessible , 
tourniquets should be placed before the patient is extricated from the veh icle and 
reassessed periodically after movement to ensure that the tourniquet has not 
been displaced or loosened. 
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Although the military and civilian environments are substantially different, 
there are still a variety of mass casualty incidents (MCis) that occur in the civilian 
world. For example, terrorist attacks, natural disasters, industrial accidents , and 
gang warfare can all result in a large number of seriously injured patients. Due to 
the relatively low risks associated with proper tourniquet use, EMS providers 
should be taught to apply tour:niquets early on in the mass casualty triage 
process and reassess their need later when more time and resources become 
available. A direct analogue to the "care under fire" provided during combat is 
tactical EMS, where specially trained EMTs support high-risk law enforcement 
missions such as serving warrants, hostage situations, and arrests of dangerous 
criminals. These operations are usually performed by SWAT teams because of 
the increased likelihood of gun battles. In these situations, tourniquets should be 
applied to any limb injured by penetrating trauma such as gunshot wounds , stab 
wounds, or fragmentation from explosions. Once an officer, suspect, or 
bystander is removed from the firefight, the tourniquet can be reassessed. 
Whenever possible, the time that a tourniquet is kept in place should be 
minimized . Obviously, rapid transportation to an appropriate hospital is very 
important. As suggested by Lee et al. , patients arriving to a hospital should be 
given a high priority for triage. When EMTs transport patients with strokes or 
heart attacks, they notify the receiving hospital in advance to have the 
appropriate personnel and equipment ready to minimize the time from patient 
arrival to treatment. Similarly, a radio or phone notification during patient 
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transport could alert the hospital to have a trauma team, and potentially a trauma 
surgeon, activated and standing by to quickly assess the need for continued 
tourniquet use as well as any surgical procedures immediately needed. 
Finally, the need for high-quality training is apparent. Prehospital 
providers need to be comfortable with the physiology of hemorrhage, proper 
indications and procedures for tourniquet use, and when and how to loosen 
tourniquets. Military training programs like TCCC have proven that hands-on 
training is more beneficial than classroom instruction alone. EMTs should be 
very familiar with how to use the tourniquets that they carry in their equipment 
bags and on their ambulances. This training would ideally occur yearly to ensure 
a high degree of proficiency and to keep up to date on emerging trends. For 
example, several of the papers discussed in this thesis suggest that isolated limb 
cooling may reduce tissue ischemia. EMTs already cool patients with heat-
related illness and following successful resuscitation of patients in cardiac arrest, 
so this may be another easy but very helpful intervention to reduce morbidity. 
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HEMOSTATIC DRESSINGS 
Overview of Products 
Hemostatic dressings chemically assist hemostasis through a variety of 
mechanisms including concentration of clotting factors and platelets, adherence 
of erythrocytes to mucous membranes, and others (Granville-Chapman, Jacobs, 
& Midwinter, 2011 ). Used in conjunction with direct wound pressure and 
tourniquets, they can be very effective in stopping life-threatening hemorrhage. 
Hemostatic dressings also have the potential to promote hemostasis in non-
compressible regions of the body where tourniquets cannot be applied or where 
direct pressure may not be sufficient to tamponade severe bleeding . Their 
development lately has been driven by the US military, which has been seeking 
ways to prevent unnecessary combat death from hemorrhage (King et al. , 2004). 
Before an analysis of efficacy can be performed, it is necessary to first introduce 
the most common prehospital hemostatic dressings. Once this is accomplished , 
a variety of studies will be examined for dressing performance, benefits, 
limitations, and ultimately recommendations. 
QuikCiot (QC) was the first FDA-approved hemostatic dressing to be used 
in OEF and OIF. It is a mineral zeolite powder that was developed by Z-Medica 
in conjunction with the US Navy. When applied to wounds QC adsorbs water, 
which concentrates platelets and clotting factors . It is negative charged , so it 
activates the intrinsic clotting pathway to a degree. Zeolite also has the ability to 
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activate platelets, further enhancing hemostasis (Z-Medica, n.d.-a). Since it was 
developed with naval researchers, QC was deployed with Marines and Navy 
corpsmen where it has been used with mixed success. Since it is a granular 
powder, it is able to conform well to irregular wound shapes, but it is also 
displaced fairly easily by high-pressure arterial bleeding. The greatest concern 
with QuikCiot, however, has been that it generates an exothermic reaction that 
raises wound temperatures and causes superficial burns (D'AIIeyrand , Dutton , & 
Pollak, 201 0). 
In an effort to reduce the reaction temperature and make QuikCiot easier 
to apply and remove, Z-Medica created QuikCiot Advanced Clotting Sponge 
(ACS). ACS is a series of mesh bags containing partially-hydrated zeolite beads. 
The dressings still result in elevated wound temperatures for the first few 
minutes, but they are considerably easier to apply to most wounds , even in the 
face of high-pressure arterial hemorrhage (D'AIIeyrand et al., 201 0). QuikCiot 
ACS has been fielded with the US military as well as with civilian EMS and law 
enforcement personnel (Z-Medica, n.d.-a). 
Released in 2008, the latest product in the Z-Medica line is Combat 
Gauze (CG), the current standard of care for US military prehospital providers. 
CG is composed of kaolin-impregnated nonwoven gauze. A potent initiator of the 
intrinsic clotting pathway, kaolin is reported to be more effective than zeolite at 
promoting coagulation. Combat Gauze comes in 3 inch by 4 yard rolls and can 
be applied to smaller wounds or packed in larger wounds. Z-Medica produces a 
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whole line of FDA-approved kaolin products, including a 4 inch by 4 inch CG 
precursor called the X-Sponge (XS) (Granville-Chapman et al. , 2011 ; Kheirabadi , 
Scherer, Estep, Dubick, & Holcomb, 2009; Z-Medica, n.d.-b). 
Concurrently with their Navy counterparts, US Army researchers were 
helping to develop HemCon (HC), a chitosan-based dressing released shortly 
after QuikCiot and fielded primarily by Army combat medics (Aiam et al. , 2005). 
Chitosan is produced when chitin (poly-N-acetyl glucosamine ), a naturally-
occurring compound in shellfish and algae, is deacetylated by 70% or more 
(D'AIIeyrand et al. , 201 0). It is considered to be a mucoadhesive agent; it is 
positively charged , which causes it to bind strongly to negatively-charged 
erythrocytes and damaged endothelial cells (HemCon , n.d.-a) . In addition , it has 
been shown to have antibacterial properties in animals (Ong , Wu, Moochhala, 
Tan , & Lu , 2008). 
The original HemCon bandage comes as a stiff, 4 inch by 4 inch wafer 
coated on one side with chitosan . After a number of animal studies and combat 
uses, it was discovered that HC worked very well when it could make a good 
seal. However, when it was placed on large, jagged , or irregular wounds , it was 
far less effective. So, HemCon developed two improved versions . One was a 
pre-softened, more flexible version called HemCon RTS (HCs) (Kheirabadi, 
Scherer, et al. , 2009), and the other is double-sided strip coated in chitosan 
called ChitoFiex (CF) (HemCon , n.d.-b; Littlejohn et al. , 2011 ). 
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Chitosan dressings are also produced in a powered form - Celox (CX) is 
such a product. It was designed to exploit the advantages of HemCon (clotting 
independent of normal coagulation pathways) and QuikCiot (easy to apply to any 
wound shape or size), while avoiding their disadvantages such as inadequate 
wound contact (HC), exothermic reactions (QC), and non-biodegradable 
materials (QC) (D'AIIeyrand et al. , 201 0). Celox is non-allergenic, non-
exothermic, inexpensive, and performs well in hypothermic blood samples. For 
deep penetrating trauma wounds Celox produces Celox-A (CXa), a simple plastic 
applicator containing Celox granules (Celox, n.d .). Yet another version, Celox-D 
(CXb ), consists of four bags of Celox powder that dissolve within ten seconds 
when exposed to blood. This version was intended to prevent brisk hemorrhage 
from displacing loose powder (Kheirabadi, Scherer, et al. , 2009). 
There are also several non-chitosan powdered agents that are currently 
being evaluated . WoundStat (WS) consists of granular smectite (containing 
various mineral silicates) that absorbs water and forms a clay. The clay can 
conform to varying wound geography, adheres well to tissue , and activates the 
intrinsic clotting pathway with its negative charges. Super Quick Relief (SQR) 
consists of potassium-iron-oxyacid salt and other minerals. When it comes in 
contact with blood , it forms a barrier that seals off the hemorrhage site 
(Kheirabadi , Edens, et al. , 2009). lnstaclot comes as 100 g of a proprietary 
mixture in small , dissolvable bags. It is very absorbant: it is reported to absorb 
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up to twelve times its weight in blood within two minutes (Franc;oise Arnaud , 
Parreno-Sadalan , Tomori, et al. , 2009). 
There is also a variety of other solid hemostatic dressings, both flexible 
and rigid. Traumastat (TS) is a nonwoven polyethylene fiber bandage coated in 
sil ica and chitosan (Kheirabadi , Scherer, et al. , 2009) . It closely resembles 
standard gauze, so it requires no special training for use (ORE-MEDIX, n.d.). 
Alphabandage (AB) is a woven material consisting of bamboo and fiberglass that 
promotes coagulation and activates platelets. BloodStop (BS) comes as 4 inch 
by 4 inch nonwoven gauze comprised of oxidized cellulose. Already used in 
obstetrics and surgical procedures, it forms a gel and expands upon contact with 
blood. Finally, there is Polymem FP-21 (FP-21 ), a rigid 4 inch by 4 inch wafer 
impregnated with chitosan and Dextran. Like BS, FP-21 forms a gel upon 
contact with blood that can also absorb approximately five times its weight in 
blood (Franc;oise Arnaud, Parreno-Sadalan , Tomori , et al. , 2009). 
Beyond these products, which are evaluated in the following studies, there 
are two effective hemostatic dressings that commonly appear in the literature but 
are not suitable for the prehospital setting due to cost. Rapid Deployment 
Hemostat (RDH) is a chitin-based (not chitosan) dressing that is believed to 
activate platelets thereby releasing vasoconstrictors and initiating the intrinsic 
clotting pathway. RDH-3 , or modified RDH , comes as chitin-impregnated gauze. 
These dressings cost approximately $300 each. An even more effective 
dressing was developed by the American Red Cross. The Dry Fibrin Sealant 
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Dressing (DFSD) contains purified human fibrinogen, thrombin, calcium, and 
FXIII on a temperature-stable, absorbant dressing. Although it works remarkably 
well in laboratory studies, DFSD is not FDA approved and costs approximately 
$1000 per dressing (D'AIIeyrand et al., 201 0; Granville-Chapman et al. , 2011 ). 
Animal Models 
The majority of hemostatic dressing efficacy studies have been pre-
clinical , animal trials. A 2011 review of these studies found 37 animal trials and 
only 6 human trials (Granville-Chapman et al. , 2011 ). A complete analysis of 
each of these is beyond the scope of this thesis, so several larger-scale animal 
studies are presented here with a bias towards studies comparing multiple 
products. Each of the selected studies was published in 2008 or later and 
focuses on evaluating efficacy of the newer, more promising hemostatic 
dressings, especially when compared to traditional treatment (a standard gauze 
dressing) or first-generation hemostatic dressings like QuikCiot and HemCon. 
Most of these studies used swine models, but there are a number of differences 
between them in terms of injury mechanism and treatment protocols that 
introduce confounding variables. Therefore , each study will be presented 
individually. 
The first of these selected studies compared Celox powder to QuikCiot 
and HemCon , which were the standards of care in prehospital combat medicine 
at the time per TCCC guidelines (Kazen , Kircher, Henao, Godinez, & Johnson, 
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2008). A lethal transection of the femoral vessels was performed in 48 swine, 
which were separated into four groups: eelox (eX), Hemeon (He), Quikelot 
(Qe), and a control , standard gauze (SG). Each pig was allowed to bleed freely 
for three minutes, simulating hemorrhage in a combat casualty that might occur 
before treatment could be initiated. After this period , the specified dressing was 
applied according to manufacturer's instructions, and direct pressure was applied 
for five minutes. Upon release of manual pressure , at the eight minute mark, a 
standard-issue compression dressing was applied and fluid resuscitation was 
begun : 500 ml of 6% hetastarch in LR was administered intravenously over 30 
minutes. Each animal was monitored for rebleeding until death occurred or 180 
minutes had elapsed. Exhaled carbon dioxide (ETe02 ) , oxygen saturation , 
mean arterial pressure, respiratory rate, and rectal temperature were monitored 
and recorded every five minutes to ensure physiological consistency between 
pigs. The results of the trial are presented in Table 2. 
Table 2: Celox Dressings versus QuikCiot, HemCon, and Standard Gauze. 
Data adapted from Kazen et al. , 2008. 
Product Rebleeding p Survival · p Blood Loss 
ex 0% < 0.001 100% 0.018 66.3% 
oe 8% 0.001 92% NS 66 .4% 
He 33% 0.038 67% NS 68.7% 
SG 83% - 50% - 69.7% 
Out of the tested dressings, eelox performed the best. None of the ex 
pigs experienced rebleeding and all survived . Survival was correlated with lower 
incidence of rebleeding and less overall blood loss. Each of the tested dressings 
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significantly reduced the incidence of rebleeding after five minutes of manual 
compression , but only Celox was shown to significantly reduce mortality. Blood 
loss was calculated by assuming a total porcine blood volume of 70 mllkg. The 
authors pointed out that each of the pigs lost greater than 40% of their total 
estimated blood volume, which is the standard threshold for Type IV (severe) 
hemorrhagic shock (Kazen et al., 2008). 
The Celox seemed to work so well because it was easily distributed within 
the wound site and was able to surround the transected vessels . The HemCon, 
which is also a chitosan-based dressing, worked very quickly and very well when 
the rigid wafer was able to make to make good contact with the damaged 
vessels. However, when a good seal was not formed, HC resulted in fatal 
rebleeding every time. In comparison, QuikCiot also seemed to be effective in 
nearly all cases except in one pig where it migrated away from the injury site and 
did not effect hemostasis (Kazen et al., 2008). 
With chitosan dressings showing great efficacy at hemostasis and 
potential antimicrobial benefits as well, Ong et al. sought to develop an 
experimental dressing that enhanced both of those properties (Ong et al. , 2008). 
Polyphosphate was chosen for its known procoagulant properties. When 45-unit 
polymers of polyphosphate were added to chitosan in a 10% (1 0:1 chitosan to 
polyphosphate) mixture, the researchers found accelerated blood clotting (p = 
0.011 ), greater platelet adhesion (p = 0.002) , expedited thrombin generation (p = 
0.002) , and greater blood absorption than ordinary chitosan (p < 0.001 ). 
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Furthermore, the added silver proved very effective at enriching the bactericidal 
properties of the chitosan dressing. · In vitro, it completely eliminated 
Pseudomonas aeruginosa and killed over 99.99% of Staphylococcus aureus, two 
common infections in injured soldiers . The dressing also reduced mortality in 
mice infected with P. aeruginosa from 90% to 14.3%. While it caused severe 
cytotoxicity to the mice's fibroblasts (in histological studies), the silver did not 
impact wound healing in any appreciable way. The authors noted that Acticoat, a 
silver preparation commonly used in clinical settings, contains far more silver 
(3011 ).!g/cm2 versus 24 ).!g/cm2). As infection by multiple-drug-resistant strains 
of bacteria is a serious and worsening problem in both civilian and military 
medicine, this study demonstrates that hemostatic dressings can be modified to 
promote coagulation and wound control. 
In 2009, Sohn et al. conducted a study to compare the efficacy of 
HemCon (a rigid , one-sided chitosan wafer) , ChitoFiex (a flexible , double-sided 
chitosan roll) , and Celox (chitosan powder). This study differs from other animal 
studies in two significant ways. Instead of surgeons, combat medics worked in 
teams of two to apply the dressings and maintain direct pressure in an attempt to 
more closely simulate battlefield casualty care . In addition , this study used 62 
goats instead of pigs, which are typically used for the similarity of their 
cardiovascular system to that of humans. 123 partial arterial transections were 
performed and , before applying any of the chitosan agents, a standard gauze 
dressing was placed to attempt hemostasis. This was unsuccessful in 99% (122) 
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of the trials, so one of the hemostatic dressings was then placed with 
compression for two minutes, observed for rebleeding , and compressed for an 
additional two minutes if necessary (Sohn et al. , 2009). The results are 
presented in Table 3. 
Table 3: Hemostasis in 3 Chitosan Dressings. Data adapted from Sohn et al. , 
2009. 
Hemostasis 
Agent 2 min 4min 
HC 36% 53% 
CF 44% 76% 
ex 38% 69% 
Hemostasis was ultimately achieved in all but 40 (33%) of the goats. Of 
the failures , 30% were directly attributable to improper dressing application . 
Although the ChitoFiex dressings demonstrated better hemostasis at the two and 
four minute marks, the better performance was not statistically significant when 
compared to HemCon and Celox (p > 0.05). This study did provide some helpful 
conclusions, however. For one thing , it was evident that all forms of chitosan 
dressings are more effective than standard gauze at controlling hemorrhage. 
The combat medics were surveyed at the end of their participation , yielding 
interesting results . 80% of them reported that Celox was the easiest dressing to 
apply, but 60% still preferred the ChitoFiex dressing , likely because of its 
similarity to the standard gauze dressing. Even more (77%) preferred ChitoFiex 
over HemCon, likely because it was less rigid and easier to conform to wound 
geography (Sohn et al. , 2009) . 
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Kheirabadi et al. have been very active in hemostatic dressing research. 
Following the previous three studies, they evaluated the efficacy of some newer 
dressings: HemCon RTS.(HCs), Celox-D (CXb), Traumastat (TS), and Combat 
Gauze (CG). Each pig underwent a splenectomy followed by a 6 mm right 
femoral arteriotomy with a 45 second free bleeding period. Then , the hemostatic 
dressing for that trial was applied , covered with a standard laparotomy sponge, 
and compressed manually for two minutes. Fluid resuscitation was initiated 30 
seconds after the dressings were placed with 500 ml of Hextend, the preferred 
prehospital combat colloid, given at 100 mllmin to reach a MAP of 65 mmHg 
(roughly equivalent to a SBP of 90 mmHg). MAPs were maintained at that level 
via LR infusion at 100 mllmin to a maximum of 10 liters total volume infused. 
After two minutes of compression, the laparotomy sponges were removed and 
the hemostatic dressings were monitored for three minutes for rebleeding. If that 
occurred , the failed dressing was removed and replaced by a fresh dressing and 
direct, manual pressure was reapplied for another two minutes. That procedure 
was only performed once; additional rebleeding was allowed to proceed without 
intervention. Each pig was monitored for 180 minutes or until death , whichever 
occurred first (Kheirabadi, Scherer, et al., 2009). 
Initial hemostasis was poor in all dressings, suggesting inadequate 
compression times or the severity of the injury model. Hemostasis was not 
achieved in the first six trials of HCs or CXb, so additional trials were not 
conducted. The authors observed that HCs was not able to prevent rebleeding 
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once fluid resuscitation raised the MAP up to 65 mmHg, and the CXb packaging 
appeared to interfere with powder distribution throughout the wound . Initial 
hemostasis was achieved in 1/10 TS pigs, 3/10 CG pigs , and 1/6 SG pigs. 
Survival rates were 20%, 80%, and 33%, respectively. Although only three of the 
CG pigs achieved hemostasis within the first three minutes after cessation of 
manual pressure, five more stopped bleeding after 12-26 minutes and all eight 
survived . The average blood loss in CG pigs was half that of TS and SG pigs, 
but that difference was not statistically significant due to the considerable 
variability of the data (Kheirabadi , Scherer, et al. , 2009). 
Histological evaluation of treated wounds showed that HCs tended to 
cause the least amount of tissue damage; TS caused slightly more; and CG, 
CXb, and SG all caused similar, and more, tissue damage. The long-term 
implications of these findings are unknown. TEG testing of clotting ability 
revealed that HCs, TS, and CXb had neutral or decreased effects on clotting , but 
CG demonstrated faster clotting times and stronger clots. Despite its 
shortcomings, namely that it didn 't immediately stop hemorrhage and that heavy 
bleeding resumed upon dressing removal , Combat Gauze was recommended to 
replace HemCon and QuikCiot as the first-line combat hemostatic dressing 
(Kheirabadi , Scherer, et al. , 2009). That recommendation was adopted by the 
TCCC committee and SG has subsequently been the dressing of choice on the 
battlefield (Kheirabadi et al. , 2011 ). 
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They conducted a follow-up study that compared WoundStat (WS), Super 
Quick Relief (SQR), eelox powder (eX), Hemeon (He), and Quikelot Aes 
(AeS). The experimental procedure was identical to their previous one except 
that the LR infusion following the 500 ml of Hextend was limited to 12 liters 
instead of 10 and a laparotomy sponge was not applied over theWS (Kheirabadi , 
Edens, et al., 2009). Some of their results are reproduced in Table 4. 
Table 4: Comparison of Powdered Hemostatic Agents. Data adapted from 
Kheirabadi et al 2009 ., 
Initial Survival Peak 
Agent n Hemostasis Survival Time (min) Temp (°C) 
ws 10 60% 100% 180 36.7 ± 0.22 
SQR 10 90% 70% 164.0 ± 8.2 53 .5 ± 1.9 
ex 10 70% 60% 138.1 ± 18 36.6 ± 0.28 
He 10 60% 10% 83.3 ± 12 36.1 ± 0.34 
AeS 6 0% 17% 83.3 ± 21 43.6 ± 0.98 
Notably, hemostasis was initially achieved in most of the pigs, except in 
the AeS group, where none of the first six trials resulted in any hemostasis. The 
sole surviving pig in that group lived for three hours despite ongoing hemorrhage. 
WS, SQR, and ex all had less blood loss, and lower mortality, than He and Aes 
(p < 0.05). ex and He dressings were rather effective initially, but when 
rebleeding started, it became lethal. Although not statistically significant, the 
AeS dressings elevated wound temperatures . In comparison , SQR significantly 
(p < 0.05) elevated wound temperatures and caused thermal tissue damage 
including widespread axonal necrosis in nerves. The superior performance of 
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WS and SQR was attributed to their procoagulant properties. They formed rapid 
and strong clots, as measured by TEG. The two downsides toWS were noted to 
be that it has to be completely removed from a wound and that it has the 
potential to cause thromboemboli (Kheirabadi , Edens, et al., 2009). 
A more rigorous evaluation of hemostatic dressings was performed in two 
studies by Arnaud et al. They evaluated four granular dressings (QuikCiot ACS, 
Celox, lnstaclot, and WoundStat), three solid but flexible dressings (Alpha 
bandage, BloodStop, and X-Sponge), and three rigid dressings (ChitoFiex, 
HemCon, and Polymem FP-21) in comparison to standard gauze. The first study 
tested a groin transection model (Arnaud , Parreno-Sadalan , Tomori , et al. , 2009, 
p. 1 0). Yorkshire pigs sustained a complete transection of the femoral 
vasculature near the groin and were allowed to free bleed for two minutes. At 
that time, the randomized .dressing was placed and five minutes of direct 
pressure were applied at 175 ± 28 mmHg. Starting fifteen minutes after injury, 
500 ml of Hextend was administered intravenously over thirty minutes. The pigs 
were monitored for rebleeding and death for up to 180 minutes. The second 
study employed a femoral artery puncture model that allowed for 45 seconds of 
free bleeding (Arnaud , Teranishi , Tomori , Carr, & McCarron , 2009) . Besides the 
differences in injury mechanism and free bleed time , the studies' procedures 
were identical. 
In both studies, all of the hemostatic dressings performed better than 
standard gauze and there were no statistically significant differences between all 
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of the dressings when their data were pooled. However, the authors separated 
the dressings into a Top 4 group and Bottom 4 group for each study. When 
these two groups were compared , statistically significant differences were noted . 
In the transection study, the Top 4 consisted of ex, 1e, WS, and XS while the 
Bottom 4 were BS, eF, FP-21, and He (Arnaud, Parreno-Sadalan , Tomori, et al. , 
2009). The Top 4 had better survival rates and times (84.4% & 160 ± 13 min 
versus 50% & 114 ± 75 min, p < 0.01) than the Bottom 4 , and all performed 
better than SG (37% & 104 ± 72 min, p < 0.05). The Top 4 also had less 
frequent rebleeding and lower overall blood loss (p < 0.05). For all dressings, 
direct pressure was a major contributor to success ; the authors emphasized that 
hemostatic dressings should not be treated as replacements for basic 
hemorrhage control methods. Among the Bottom 4 , He was (again) found to 
only be effective when a good seal was made, FP-21 had "impressive" 
procoagulant properties but also had difficulty conforming to irregular wounds , 
and BS was found to be too small to be effective per the manufacturer's 
instructions. 
In the puncture study, the Top 4 were AeS, ex, WS, and XS while BS, 
eF, FP-21 , and He again comprised the Bottom 4 (Arnaud , Teranishi , et al. , 
2009 ). The Top 4 had better survival than the Bottom 4 (78 ± 12% & 160 ± 13 
min versus 25 ± 0% & 114 ± 75 min , p < 0.01) and the standard gauze (p < 
0.001 ). They also permitted less overall blood loss (25.3 ± 18.4% EBV v. 53 .0 ± 
18.4% EBV, p < 0.05). The severity of the arterial puncture injury was found to 
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be several-fold. In these wounds, there is high-pressure hemorrhage that can 
easily dislodge dressings, especially powders, and rebleeding was common with 
most dressings. Upon release of manual pressure, rebleeding occurred in 50-
62.5% of the Top 4 and 75-100% of the others. Then , after MAP was elevated to 
65 mmHg, rebleeding occurred in up to 50% of the Top 4 and in 66.7-100% of 
the others. Overall rebleeding rates were 35 ± 49% for the Top 4 and 79 ± 43% 
for the Bottom 4 (p < 0.01 ). Since there was less pre-treatment blood loss in this 
model as compared to the transection , blood pressures were relatively elevated 
and complicated clot formation and stabilization. Again, the five minute 
compression period was determined to be crucial to hemostatic dressing 
performance. 
From these two studies, Arnaud et al. declared Celox, QuikCiot ACS, 
WoundStat, and X-Sponge to be the most efficacious hemostatic dressings. 
They went on to publish the results of two more dressings, Combat Gauze and 
Traumastat, tested in both the groin transection and groin puncture models 
(Arnaud et al., 2009) . CG had survival rates of 100% and 88% and TS had 
survival rates of 100% and 50% in the transection and puncture models, 
respectively. Additional in vitro studies showed that CG had greater absorption 
(p < 0.05) and stronger procoagulant effects (p < 0.05) than TS. CG and TS 
were found to be lightweight, easy to use , and suitable for storage within a wide 
temperature range . Overall , the authors concluded that CG had similar 
performance to XS in the previous experiments , probably because they are both 
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kaolin-based products, while TS was outperformed by CX, another chitosan -
based dressing. 
In contrast to the promising data from all of these animal studies, Littlejohn 
et al. found no statistically significant differences in hemostatic performance 
between Celox-A (CXa), ChitoFiex, Combat Gauze, WoundStat, and standard 
gauze. Their experiments utilized 80 pigs assigned at random to each of the five 
groups. A complex groin injury was approximated by a small penetrating wound 
leading to a complete transection of the femoral vasculature. After 45 seconds of 
free bleeding, each test dressing was applied with five minutes of direct pressure. 
Ten minutes after injury, fluid resuscitation was provided with 500 ml of 6% 
hetastarch in NS given over 30 minutes. As in previous studies, the pigs were 
monitored for 180 minutes or until death (Littlejohn et al. , 2011 ). 
Lacking statistical significance, CXa provided the best initial hemostasis 
(100%), the lowest rebleed rate (33%), and the best survival (88%). Two pigs 
died unexpectedly after otherwise-successful treatment with WS . As WS was 
removed from TCCC guidelines in February 2009 after reports of tissue 
inflammation and embolization, the authors speculated that the latter may have 
been responsible . The roll dressings, which had generally been favored in 
previous studies, were found to be clumsy. If CF was not completely unrolled 
prior to application , it would stick together and become unusable. Though CG 
did not suffer that problem, it was twelve feet long and took longer to unroll , 
delaying hemostasis. Ultimately, they concluded that in small , penetrating 
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wounds with significant vascular injuries wound packing was extremely important 
and that standard gauze is likely just as effective as hemostatic dressings 
(Littlejohn et al. , 2011 ). 
The dilemma encountered when comparing efficacy studies of hemostatic 
dressings is that experimental procedures vary from laboratory to laboratory and 
even between studies by the same investigators. A panel of experts met in June 
of 2009 to discuss hemostatic dressing testing and to develop a standardized 
protocol (Kheirabadi et al., 2011 ). Their proposed model involves avoiding 
splenectomy and inflicting a 6 mm femoral arteriotomy followed by thirty seconds 
of uncontrolled hemorrhage. Then, investigators would be given up to a minute 
to adequately pack the wound to be followed by two minutes of direct 
compression . Fluid resuscitation would be more conservative than in the past. 
500 ml of warm Hextend would be infused at a maximum rate of 50 ml/min to 
raise the MAP to 65 mmHg. After that, a maximum of 5 liters of warm LR could 
be infused to maintain MAP between 60 and 65 mmHg and pigs would be 
monitored until death occurs or 150 minutes elapses. Combat Gauze , the 
current front-line hemostatic dressing , would be used as the control. 
The experts also agreed that an ideal hemostatic dressing has not yet 
been developed for tactical use (Kheirabadi et al. , 2011 ). Their specifications for 
such a dressing include FDA approval , ability to stop severe hemorrhage 
(whether arterial , venous, or mixed) within two minutes, no side effects or toxicity, 
lightweight, high durability, easy to use, requires little training , and functionality 
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over a wide range of temperatures. They would also like for it to fit complex 
wounds, be easily removable but also be bioabsorbable and biodegradable, have 
a shelf-life of at least two years, be inexpensive, and be effective in junctional 
wounds that are not amenable to tourniquet use. 
Combat Data 
As previously mentioned , most of the hemostatic dressing efficiency data 
comes from animal trials. When promising, new dressings are identified they are 
rushed into service in an attempt to save as many lives as possible on the 
battlefield . The military has not waited for large, randomized human trials before 
making these decisions and TCCC guidelines reflect this as hemostatic dressing 
recommendations have changed mostly based on findings from animal studies. 
Despite the higher incidence of severe trauma in a combat setting , 
hemostatic dressing use has been relatively low. Between April and October 
2006, one CSH noted that out of 1,691 trauma patients, only 0.4% received 
HemCon (HC) or QuikCiot (QC) in the field , compared to 2.6% of trauma patients 
overall (Cox, Schreiber, McManus, Wade, & Holcomb, 2009). This low utilization 
rate was believed to be a combination of widespread tourniquet use and bias 
towards simply using standard gauze dressings prehospitally. 
A 2006 study evaluated 64 instances of HC use. 55% of the injuries were 
to extremities , while most of the others were to truncal or junctional areas such 
as the torso, groin , and buttocks. 66% of the dressings were placed after 
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standard gauze failed to achieve hemostasis. In all but two cases, where the 
wafers were blindly inserted into a deep wound, HC stopped or greatly slowed 
the hemorrhage, resulting in a 97% efficacy rate (Wedmore, McManus, Pusateri , 
& Holcomb, 2006). In comparison , a 2008 study reviewed 103 uses of QC; 69 in 
OIF and 34 in civilian prehospital and in-hospital settings. QC was able to 
achieve hemostasis in 92% of patients, three of whom suffered burns and one of 
whom required extensive skin grafting as a result (Rhee et al. , 2008). 
In the CSH studied mentioned above, 50 HC or QC dressings were 
applied to 44 patients (Cox et al. , 2009). Because the area was predominantly 
patrolled by Army units, most of the casualties (40) received HC dressings. 
Three got QC, and one received both HC and QC. Overall , these patients had a 
95% survival rate . The surgeon who cared for each of these patients determined 
that the applied hemostatic dressing was partially or entirely responsible for 
hemorrhage control. The two patients who died both had catastrophic injuries as 
evidenced by Injury Severity Scores of 75. Half of the QC patients sustained 
burns from the exothermic reaction. While there were no adverse advents 
associated with HC use, it was noted that when the wafers were removed after 
being in place for 24-48 hours, the wounds took on a purulent, infected look. 
Paradoxically, the chitosan is believed to have antibacterial properties. 
Unfortunately, there are not yet any studies detailing large scale use of the 
newer hemostatic dressings in humans, but there are indications that they work 
just as well in people as they do in animal models. An obstetrical case study 
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from Germany reported that Celox powder was able to stop severe postpartum 
hemorrhage that was refractory to traditional hemostatic procedures following a 
caesarian section (Schmid, Rezniczek, Rolf, & Maul, 2012). As the newer 
hemostatic dressings continue to be developed and fielded , military and civilian 
researchers will be able to collect and analyze efficacy data to more accurately 
determine reasonable guidelines and recommendations for their use. 
Recommendations 
Hemostatic dressings are effective adjuncts to traditional hemorrhage 
control methods in compressible hemorrhage. Whether or not they are used in 
conjunction with tourniquets, hemostatic dressings help to accelerate 
coagulation , prevent rebleeding , and increase survival in extreme hemorrhage of 
arterial , venous , or mixed origin . Based on the available literature, the best 
civilian prehospital dressings appear to be Combat Gauze (CG) and Celox (CX). 
They are both effective, inexpensive, have long shelf-lives, are easy to use, are 
hypoallergenic and non-exothermic, and have minimal (if any) side effects. 
Combat Gauze has several important advantages. It's a bulky dressing 
that can pack a deep wound and wrap around a wound with large surface area. 
It is extremely flexible and requires no substantial training beyond that for 
standard gauze dressings. CG's kaolin coating activates the intrinsic clotting 
pathway and CG is particularly effective in severe arterial hemorrhage. Celox 
also has its advantages. Its granular form allows it to be applied easily and 
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thoroughly to wounds of any shape or size. Since it relies on hemagglutination 
and not the clotting cascade, it is still effective in coagulopathic patients and 
those on anticoagulants like Coumadin and heparin that are very common in the 
civilian population. Additionally, chitosan lends CX antimicrobial properties that 
will likely provide great benefits to patients in the reduction of morbidity and 
mortality. Traumatic injuries are often contaminated, and bacteria with resistance 
to multiple antibiotics are becoming a greater and greater threat to hospitalized 
patients as time goes on. 
In contrast , many of the other dressings should probably be avoided in the 
civilian prehospital setting. The original hemostatic dressing , QuikCiot, causes 
superficial burns with its exothermic reaction , and the follow-on QuikCiot ACS still 
results in elevated wound temperatures. Similarly, Super Quick Relief has been 
shown to significantly elevate wound temperatures , causing tissue damage and 
nerve necrosis as demonstrated by histological preparations. HemCon wafers 
are too rigid to adequately fit many wounds and study after study shows that they 
are unable to work effectively without a good seal and that rebleeding after initial 
hemostasis frequently leads to fatal blood loss. ChitoFiex is substantially more 
effective but can be difficult to use and has a propensity for sticking to itself if not 
handled carefully. WoundStat, which showed great promise, has unfortunately 
been shown to generate thromboemboli and is no longer used by the US military. 
It also must be completely removed from a wound after use , which is fairly 
tedious and difficult to do. 
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By carrying CG and CX, EMTs will have access to safe and inexpensive 
hemostatic dressings that are effective over a variety of wound types and patient 
demographics. It is important to emphasize during training , however, that 
hemostatic dressings are not substitutes for basic hemorrhage control techniques 
and that direct pressure, in particular, is critical for their efficacy. As the US 
military continues to develop and evaluate new hemostatic dressings, EMTs and 
their medical directors should continue to consider them for civilian use, 
especially as hemostatic function and antimicrobial properties are enhanced. 
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PHARMACOLOGICAL INTERVENTIONS 
Recombinant Factor VIla 
Massive hemorrhage can lead to deficiency of clotting factors , which 
further complicates hemostasis. One of the earliest explored solutions to this 
problem during OEF and OIF was the use of recombinant activated Factor VII 
(rFVIIa). Hemophiliacs, who are deficient in Factors VIII and IX (integral players 
in the intrinsic clotting pathway), have long been prescribed rFVIIa as it 
compensates for these deficiencies by activating the extrinsic pathway. FVIIa 
usually exists in minute amounts in the bloodstream and has a long half-life, so it 
can be quickly depleted in on-going hemorrhage (Devlin , 201 0). Since FVIIa is 
only active when exposed to tissue factor, it does not cause systemic coagulation 
when administered intravenously. On the contrary, it has a well-established 
safety profile. There have only been serious thrombotic complications in 0.05% 
of 480,000 doses given to hemophiliacs (Martinowitz, Zaarur, Yaron , Blumenfeld , 
& Martonovits, 2004 ). Initial anecdotal reports from battlefield hospitals 
suggested that off-label rFVIIa use was very helpful in arresting hemorrhage in 
severely injured patients. Although its mechanism of action wasn 't completely 
clear, it was believed to increase thrombin generation on activated platelets and 
promote localization and adhesion of platelets (Hoffman , 2004 ). 
Despite its early promise, rFVIIa does not appear to be an efficacious 
intervention in trauma patients . As previously established , hemorrhage causes 
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hypoperfusion that results in anaerobic metabolism, which in turn causes 
acidosis. In acidic environments all clotting factors are less active, and rFVIIa is 
similarly affected (Hoffman, 2004). A randomized, double-blind study 
demonstrated that rFVIIa resulted in statistically-significant reduction in blood 
transfusion requirements of blunt trauma patients and a trend towards significant 
reduction in penetrating trauma patients, but there was no discernible 
improvement in patient outcomes (Boffard et al., 2005). Furthermore, another 
large-scale clinical trial was canceled after only one third of anticipated patients 
had been enrolled because there was no significant difference in mortality rates 
or blood product infusion requirements between rFVIIa and placebo groups 
(Hauser et al., 201 0). Finally, a meta-analysis of 26 clinical trials evaluating 
rFVIIa use in non-hemophiliac patients found no differences in mortality, blood 
transfusion requirements, or adverse thrombotic events between treatment and 
placebo groups (Lin , Stanworth, Birchall , Doree, & Hyde, 2011 ). 
While rFVIIa does not appear to warrant a place in management of 
traumatic hemorrhage, there might be a future role for other clotting enzymes. 
Recent research suggests that prothrombin complex concentrates may be 
effective and safe adjuncts to hemorrhage control in trauma (Aiam & Velmahos, 
2011 ). They appear to rapidly nullify the anticoagulation seen in patients on 
Coumadin , and might be effective at promoting rapid hemostasis in all trauma 
patients. Also promising is freeze-dried plasma. Used extensively during World 
War II , freeze-dried plasma is easily stored and administered, and it provides _ 
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similar levels of clotting factors to patients as are found in fresh frozen plasma 
(Dubick, 2011 ). 
Antifibrinolytic Therapy: Tranexamic Acid 
One of the ironic consequences of severe traumatic hemorrhage is that it 
often creates a hyperfibrinolytic state that perpetuates the hemorrhage. For this 
reason , researchers have been trying to identify an effective antifibrinolytic agent 
for use in trauma patients. Just as in tourniquet use, surgery may offer some 
answers. Aprotinin is a nonspecific serine protease that forms an irreversible 
inhibitory complex with plasmin. It had been commonly used to reduce surgical 
blood loss, but its FDA approval was revoked after reports of increased mortality 
during cardiac bypass (Perkins et al., 2008) and it has been shown to be 
ineffective at reversing pre-existing coagulopathy (Hoffman, 2004 ). It was also 
shown to have 45% higher mortality than tranexamic acid, which is introduced 
below, in cardiac surgeries in general (Takagi, Manabe, Kawai, Goto, & 
Umemoto, 2009). 
Alternatively, there are two commonly used lysine antifibrinolytics, epsilon 
aminocaproic acid and tranexamic acid (TXA). They prevent plasminogen 
activation and subsequent fibrinolysis by occupying its lysine-binding sites. 
While there are no studies of aminocaproic acid in trauma patients, tranexamic 
acid appears to be an exciting potential treatment for hemorrhage (Roberts , 
Shakur, Ker, & Coats, 2011 ). As 90% of trauma deaths worldwide occur in low 
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and middle-income countries, researchers have been trying to identify realistic, 
cost-effective interventions. Since TXA has demonstrated efficacy in safely 
reducing surgical blood loss in patients with normal and elevated fibrinolytic 
activity, it was selected for a large-scale study in trauma patients (Shakur et al. , 
201 0). 
In 2010, the results of this study (CRASH-2) were published. Adult trauma 
patients presenting to 27 4 hospitals in 40 different countries were evaluated for 
severe hemorrhage or risk of severe hemorrhage. To be eligible for the study, 
patients had to have been injured within the previous eight hours, have a SSP 
less than 90 mmHg and/or a heart rate greater than 110 beats per minute (or be 
at risk for significant hemorrhage per the treating physician 's clinical judgment) , 
and have no strong indications or contraindications for TXA administration. In all , 
20,211 randomized patients were enrolled in the study; 10,096 received TXA and 
10,115 received a normal saline placebo. Patients who received TXA were given 
a 1 g loading dose over ten minutes followed by another gram infused over eight 
hours. Those who received the placebo received equal volumes of NS. 
Investigators, treating physicians, and patients were all blinded to which 
treatment was being provided (Shakur et al. , 201 0). 
The primary outcome studied was in-hospital mortality within 28 days of 
injury. Cause of death was recorded as hemorrhage, occlusive vascular event 
(myocardial infarction , stroke, pulmonary embolism , or deep venous thrombosis) , 
multiple organ fai lure, head injury, or other. Overall mortality of study participants 
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was 15.3% (3,676 patients), with just over a third (35.3%) of those deaths 
occurring on the day of injury. Of the patients who died from hemorrhage, 59.9% 
died on the day of injury. The most substantial finding of this study was that TXA 
has a dramatic effect on mortality in trauma patients. TXA patients experienced 
a 9.4% reduction in mortality from all causes (14.5% v. 16.0%, p = 0.0035) and a 
14% reduction in mortality from hemorrhage (4.9% v. 5.7%, p = 0.0077) (Shakur 
et al. , 201 0). 
The secondary outcomes studied were vascular occlusive complications , 
blood transfusion rates, and need for surgical intervention. TXA patients had a 
lower risk of myocardial infarction (p = 0.035) and trended towards a lower risk of 
thrombotic complications overall (p = 0.084 ). They had no appreciable 
differences in transfusion needs or rates of surgical intervention (p = NS). The 
authors noted that decisions regarding emergency surgery and blood transfusion 
(in particular) are made soon after hospital admission , while TXA therapy was 
performed over the course of eight hours and may have had delayed effects 
(Shakur et al. , 201 0). 
Several other conclusions were made by the authors. First of all , 
treatment decisions were based off of clinical criteria and not laboratory data , so 
CRASH-2 data were unable to confirm the presence of hyperfibrinolytic states in 
the patients or whether TXA actually demonstrated antifibrinolytic effects. 
Second of all , since TXA's antifibrinolytic activity is believed to occur within 4 
hours, its mechanism of action in these trauma patients is unclear. Third of all , 
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they noted that while TXA is typically given in weight-based doses during surgical 
procedures, the demands of emergent management of trauma patients 
necessitated the selection of a fixed dose. The one gram bolus and one gram 
infusion were chosen to maximize efficacy in larger patients without 
compromising safety in smaller patients. As a result, the effects of smaller or 
larger TXA doses are unknown (Shakur et al., 201 0). 
The following year, the CRASH-2 contributors published further analysis of 
the data showing that TXA is a time-sensitive intervention in trauma patients. 
When given within an hour of injury, TXA reduces the risk of hemorrhage-related 
death by 31 .2% (5.3% v. 7.7%, p < 0.0001 ). When given between one and three 
hours of injury, it reduces that risk by 21.3% (4 .8% v. 6.1 %, p = 0.03). When 
given beyond three hours after injury, however, it shows neutral or increased risk 
of death from hemorrhage. Overall hemorrhage-related fatalities increased by 
41 .9% (4.4% v. 3.1 %, p = 0.004) in this group. While TXA's mechanism of action 
in traumatic hemorrhage is still ambiguous, the authors postulated that its 
antifibrinolytic activity might intensify the depletion of clotting factors during the 
DIC that occurs during end-stage hemorrhage, resulting in intensified 
coagulopathic bleeding (Roberts , Shakur, Afolabi , et al. , 2011 ). 
The US military conducted its own study of TXA in combat casualties 
(Morrison , Dubose, Rasmussen , & Midwinter, 2011 ). In a retrospective analysis, 
the outcomes of 896 patients were evaluated. 293 received TXA (and 125 of 
them required massive transfusion , which is discussed later in this thesis) in one 
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gram boluses per clinical judgment and 603 did not (196 of them also required 
massive transfusion). The TXA patients experienced lower mortality ( 17.4% v. 
23.9%, p = 0.03), despite having more severe injuries. An even more significant 
reduction in mortality was seen in the TXA patients who required massive 
transfusion (10+ units of packed red blood cells or whole blood given within a 24-
hour period). In this subgroup, mortality was decreased from 28.1% to 14.4% (p 
= 0.004) and incidence of coagulopathy was also reduced . While there were no 
fatalities due to vascular occlusive events, TXA patients experienced them at a 
higher rate. The authors suggested that this may be a reflection of the higher 
average injury severity of TXA patients or a result of surviving otherwise fatal 
hemorrhage. They also observed that mortality did not significantly decrease 
with TXA use until 48 hours after injury, which may implicate a TXA-mediated 
inflammatory response reduction. 
In addition to demonstrating substantial reductions in mortality from 
trauma, TXA appears to be quite cost-effective. A 2011 study used established 
economic models to evaluate cost-effectiveness in low income (Tanzania), 
middle income (India), and high income (United Kingdom) countries. Overall , 
widespread TXA use in trauma care could save 70,000 to 100,000 lives 
worldwide . Since the UK is the most similar the US, that data will be examined 
here. TXA is forecast to save 755 life years for every 1,000 trauma patients it is 
given to , at an expected cost of $64 per life year saved . These predictions are 
based on an average cost of $31 per patient, when TXA costs ($5.70 per gram) 
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and staffing salaries are factored in (Guerriero et al., 2011 ). The authors also 
point out that CRASH-2 data suggest that TXA patients are discharged from the 
hospital with fewer symptoms and disabilities than non-TXA trauma patients, so 
long-term healthcare costs may be reduced for those patients as well . 
Pharmaceuticals are often more expensive in the United States, so it is 
important to consider the realistic cost of TXA administration. In 2010, the 
military version of TXA cost $39.12 per gram and the civilian version was 
available from CVS Pharmacy for $101.99 per gram (Cap et al. , 2011 ). While 
these costs are greater than those in other countries , TXA is still an attractive 
prehospital intervention. 
As previously mentioned , TXA has been used for decades in elective 
surgeries , and it also shows promise for other hemorrhage-related problems 
such as postpartum hemorrhage (Ducloy-Bouthors et al. , 2011) and upper 
gastrointestinal bleeding (Giuud, Klingenberg, & Langholz, 2008; Hawkey, Cole , 
Mcintyre, Long , & Hawkey, 2001 ; Sabovic, Lavre , & Vujkovac, 2003 ; Von 
Holstein, Eriksson , & Kallen, 1987). However, as identified by CRASH-2 
contributors, the optimal dosage for TXA in trauma patients still has to be 
determined. It is possible that higher doses could have more beneficial effects , 
but it has been established that high doses of TXA are associated with higher 
rates of blood loss, seizures, and repeat thoracotomies in cardiac bypass 
surgeries (Sander et al. , 201 0). 
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Recommendations 
Civilian EMS provides early medical assessment and treatment in the 
prehospital setting. Most non-invasive hemostatic interventions can be 
performed by EMTs, other first responders, and bystanders alike. 
Pharmacological interventions, on the other hand, represent an area where 
advanced prehospital providers, EMT -Paramedics, can initiate efficacious and 
time-sensitive interventions before hospital arrival. Hemorrhage causes 
physiological derangements in the body that can include anticoagulant and 
hyperfibrinolytic states. This section has evaluated several proposed remedies . 
Recombinant activated Factor VII has been used in OEF and OIF to 
combat trauma-associated coagulopathy. For many reasons, such as decreased 
activity in acidotic environments, rFVIIa has not been shown to have any 
beneficial effects in trauma patients, so its use in the prehospital environment is 
not indicated or worthwhile. Current research suggests that prothrombin 
complex concentrates and freeze-dried plasma may be very effective at 
combatting coagulopathy and they may very well earn a place in prehospital 
hemorrhage control guidelines. EMTs and their medical directors should keep 
abreast of the developing literature and evaluate the feasibility of those 
interventions when more data become available. 
The area of antifibrinolytics, in comparison , is very exciting. In particular, 
tranexamic acid has been definitively shown to significantly reduce the risk of 
overall mortality and hemorrhage-related mortality in adult trauma patients 
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covering a wide range of demographics and physiologic parameters. From the 
military TXA study, it is evident that trauma patients requiring massive 
transfusion will particularly benefit from TXA administration. Moreover, TXA does 
not appear to increase the overall risk of adverse thrombotic events, blood 
transfusion requirements, or necessity of surgical intervention. Although more 
expensive in the US, TXA is still a relatively inexpensive intervention that can 
likely improve not only survival but also quality of life following traumatic injury. 
The CRASH-2 study suggests that the prehospital environment is especially 
conducive to TXA administration because its effects are very time-sensitive, it is 
administered initially as a single loading dose, and patients with severe 
hemorrhage are more likely to be transported to the hospital via EMS. As more 
and more civilian trauma centers incorporate TXA into their trauma management 
algorithms, paramedics should advocate for this medication to be included in 
their drug boxes. 
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OTHER CONSIDERATIONS 
Damage Control Resuscitation 
The most immediate threat posed by hemorrhage is inadequate perfusion 
throughout the body. Hypoperfusion can cause permanent damage to organs 
and leads to acidosis, hypothermia, and coagulopathy- the "lethal triad" seen in 
severely injured patients (Holcomb et al. , 2007). Damage control resuscitation 
(OCR) is the name given to fluid resuscitation strategies that aim to quickly 
restore perfusion in trauma patients, maximizing survivability and minimizing 
complications. Specifically, OCR provides evidence-based guidance regarding 
when fluid resuscitation is appropriate, which types of fluid are preferable, and 
how much fluid should be administered. 
The philosophy behind fluid resuscitation had long been to restore blood 
pressure to normal or elevated levels in patients with hemorrhage. Prehospitally, 
this was accomplished with large volumes of crystalloid solutions like normal 
saline (NS) and lactated ringer's (LR) ; these infusions were often continued at 
high rates within the emergency department. However, this approach presented 
a number of problems. First of all , increased blood pressure exerts greater force 
on blood clots. By elevating blood pressure to levels greater than that required 
for adequate perfusion , fluid resuscitation was making it harder for the body's 
natural hemostatic mechanisms to work. Second of all , these fluids dilute the 
blood, decreasing clotting factor concentrations and further straining the 
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coagulation process. Unlike certain blood products, crystalloids do not have any 
oxygen-carrying capacity, so they do not help to restore tissue perfusion in that 
manner. Crystalloids also equilibrate throughout the body, so large volumes of 
NS and LR can cause compartment syndrome and pulmonary edema, amongst 
other complications (Aiam & Velmahos, 2011 ). Finally, contemporary literature 
suggests that NS and LR may actually contribute to electrolyte imbalances and 
cause unfavorable immune system complications (Aiam & Velmahos, 2011; 
Dubick, 2011; Holcomb et al., 2007). 
The gold standard for OCR is resuscitation with warmed, rapidly-
administered blood products (Fox et al., 2011 ). The military has discovered that 
patients who receive packed red blood cells (PRBCs), plasma, and platelets in a 
ratio of 1:1:1 have the lowest mortality rates and fewest complications (Fox et al. , 
2011; Ling et al., 201 0; Rizoli et al., 2011 ). Given in this ratio , the blood 
components form a solution with a hematocrit of 30 , approximately 60% the 
normal concentration of clotting factors , and 80 x 1 09 platelets per liter. 
Erythrocytes play a critical role in concentrating platelets near damaged 
endothelial wall at up to seven times their normal concentrations, but this effect 
may require a hematocrit of 35 or higher (Perkins et al., 2008). Military trauma 
resuscitations often give blood components in higher ratios of PRBCs to plasma, 
like 2:1 (Holcomb et al. , 2007) , but they generally avoid ratios higher than that. 
Among a cohort of severely injured trauma patients who required massive 
transfusion , survivors averaged a PRBC-to-plasma ratio of 1.8:1 and non-
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survivors averaged 2.5:1 (Cinat et al., 1999). More recently, in OIF, patients who 
were resuscitated with an 8:1 ratio had 65% mortality as compared to 34% 
mortality in the 2.5:1 group, and 19% mortality of those who averaged 1.4:1 
(Borgman et al. , 2007). 
Massive transfusion of clotting factor-deficient fluids like PRBCs, 
crystalloids, and colloids can seriously impact the blood's ability to clot. When a 
patient has received one complete blood volume of replacement fluids , only 38% 
of his or her original blood remains; after two volumes worth, only 13% remains. 
Since total volume and erythrocytes are increased, these percentages reflect 
significantly decreased concentrations of clotting factors and platelets. 
Mathematical models of clotting factor-poor massive transfusion in patients with 
50% blood loss will have approximately 16% and 3%, respectively, of their 
original blood still in circulation (Perkins et al. , 2008). 
Clearly then one of the most valuable lessons of OCR is that plasma 
(thawed fresh frozen plasma, or FFP) is an excellent way to both maintain high 
levels of clotting factors and restore depleted fluid volume (Holcomb et al. , 2007) . 
Cryoprecipitate is often given to boost fibrinogen levels , but FFP delivers twice as 
much fibrinogen per unit and also addresses coagulopathy due to other enzyme 
deficiencies (Perkins et al. , 2008). In the most severely injured trauma patients, 
military physicians administer fresh whole blood that is collected from volunteers 
on-site and kept for only a few days (Holcomb et al. , 2007; Ling et al. , 201 0). It 
provides all of the benefits of whole blood (or blood components in whole blood 
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ratios) therapy without the added complications of stored blood, which are 
outlined in the section "Complications of Massive Transfusion" below. 
In the battlefield environment, neither crystalloids nor blood products are 
used in trauma care prehospitally for logistical reasons. Quite simply, large 
volumes of crystalloids add considerable weight and take up valuable space in 
gear bags and vehicles , and blood products are impractical to store and 
maintain. Instead, military medics use a colloid solution called Hextend. It has 
been shown to provide similar resuscitative results as crystalloids with as little as 
one third of the volume administered (Dubick, 2011 ). Medics are authorized to 
administer up to one liter of Hextend as one or two 500 ml boluses. It is only 
given to patients who present with signs of shock, such as altered mental status 
or hypotension , defined in the tactical environment as weak or absent radial 
pulses (Ling et al. , 201 0). It is often difficult to monitor blood pressures in a 
tactical environment, where there may large numbers of seriously injured patients 
in addition to ongoing fighting (Farkash et al. , 2002). 
In general , trauma patients have better outcomes and fewer complications 
when they are maintained in a "permissive hypotension" state. For patients 
without head injuries, wherein low blood pressures can cause serious brain 
damage, the targeted systolic blood pressure is approximately 80-90 mmHg 
(Dubick, 2011 ; Holcomb et al. , 2007), which roughly corresponds to a mean 
arterial pressure (MAP) of 50-65 mmHg (Farkash et al. , 2002; NAEMT, 2010) . At 
these pressures, the body's organs are adequately perfused and there is a 
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favorable environment for blood clotting and wound healing. Since achieving and 
maintaining blood pressures in this range require less fluid than attempting to 
reach a normotensive state, valuable blood products are spared and kept 
available for use by other patients. In this system, the role of crystalloids is more 
to facilitate medication administration and maintain patency of IV lines in between 
blood products than it is to replace lost blood volume. A review of military OCR 
found that it corrects the lethal triad of severe hemorrhage exceedingly well ; 
instead of unstable patients, most combat theater ICUs admit OCR patients who 
are "warm, euvolemic, and non-acidotic with a normaiiNR and minimal edema." 
(Holcomb et al., 2007). 
Temperature Management 
It has long been established that injury-associated hypothermia is strongly 
correlated with increased mortality in trauma patients . Hypothermia in trauma 
patients is strongly predictive of coagulopathy, mortality, multiple organ failure , 
length of hospital stay, and increased transfusion requirements (even in elective 
surgeries) (Wade, Salinas, Eastridge, McManus, & Holcomb, 2011 ). The 
mechanisms of coagulopathy include platelet dysfunction , slowing of the 
enzyme-mediated clotting cascades, endothelial cell abnormalities , and 
inappropriate fibrinolytic activity (Farkash et al. , 2002). 
A 1987 study evaluated mortality in 35 severely-injured trauma patients . 
Those with core body temperatures less than 32°C (indicating severe 
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hypothermia) had 100% mortality, while those with mild hypothermia or normal 
core temperatures only had 3% mortality (Jurkovich ! Greiser, Luterman , & 
Curreri , 1987). Aggressive management of hypothermia is therefore a top 
priority for hospitals upon receiving trauma patients. Correction of hypothermia is 
also a prehospital consideration , and EMTs are advised to treat trauma patients 
for shock, which includes preventing excessive body heat loss (Bledsoe et al. , 
2008). PHTLS guidelines go one step further and recommend that trauma 
patients receive warmed IV fluids (approximately 1 02°C) whenever possible 
{NAEMT, 2010). 
This PHTLS recommendation is theoretically sound , but it turns out that 
prehospital fluid administration may have little or no effect on core body 
temperature in trauma patients. A prospective study of moderately and severely 
injured combat casualties over a two year period in Lebanon showed that 
prehospital fluid resuscitation had no effect on either core temperature or PT and 
aPTT times. Even the amount of time a casualty spent between injury and 
hospital arrival had no correlation with core body temperature. Instead , the 
greatest determinant of core temperature was the injury severity (Farkash et al. , 
2002). Moderately injured patients had an average temperature of 36.8°C upon 
hospital admission , compared to 35.8°C in severely injured casualties. 
Interestingly enough , very little attention has been paid the effects of 
hyperthermia, or increased core body temperature, on trauma patient morbidity 
and mortality. A recent study examined 4,093 civilian trauma patients and 4,394 
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military trauma patients to determine the effects of abnormal body temperature 
on mortality (Wade et al., 2011 ). The normal temperature range was defined as 
36-38°C, consistent with medical conventions and a review of outcome data of 
over 600,000 trauma patients. Civilian trauma patients, identified from National 
Trauma Data Bank and three Level 1 trauma centers' records, had 3.5% 
mortality. 9.3% of them presented to the hospital with hypothermia and 2.2% 
with hyperthermia. Military trauma patients , identified from CSH records, 
experienced a 2.5% overall mortality rate. 6.0% of them arrived to a battlefield 
hospital with hypothermia, and 7.4% arrived with hyperthermia. Hypothermia 
was due to injury pathology or ambient environmental conditions, whereas 
hyperthermia was usually due to physical exertion immediately prior to injury, 
ambient environmental temperatures , and/or underlying illness or infection . 
The mortality data are presented in Table 5. It is immediately obvious that 
hypothermia and hyperthermia are associated with increased mortality in both 
the civilian and military trauma populations (p < 0.05). Hyperthermia also 
appears to play a greater role in civilian mortality than it does in military patient 
populations (p < 0.05). The authors also found that civilians who presented with 
hypothermia or hyperthermia had more severe injuries, had longer stays in the 
ICU and hospital in general , and spent more days on ventilators . Combat 
casualties who presented with hypothermia or hyperthermia had higher ISS 
scores, spent more days on ventilators and in the ICU , but did not experience 
longer hospital stays on average. They also tended to have significantly lower 
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systolic blood pressures when hypothermic than other military trauma patients 
(Wade et al. , 2011 ). 
Table 5: Mortality by Core Temperature. Data adapted from Wade et al. , 
2011 . 
Core Body Temperature 
Normal Hypothermia Hyperthermia 
Mortality (36-38°C) (< 36°C) (> 38°C) 
Civilian 
Militar 
2.3% 
1.7% 
12.3% 
11 .0% 
14.1% 
3.7% 
Regardless of all other interventions, including hemorrhage control , 
management of core body temperature in trauma patients is a top priority in 
combat medicine (Holcomb et al. , 2007). By maintaining core temperature in a 
normal range, all of the body's enzymes (including those of the clotting cascade) 
are able to perform their functions at optimal rates. It has been shown that for 
every 1 OC decrease, the clotting cascade experiences a reduction in speed of 
about 10% (Perkins et al. , 2008). Rectifying hypothermia also immediately fixes 
other coagulation problems such as platelet dysfunction. However, the previous 
study also highlights the importance of not overlooking hyperthermia in trauma 
patients as it is associated with substantial increases in mortality, especially in 
civilian patient populations. 
Complications of Massive Transfusion 
Massive transfusion (MT) is defined as the administration of ten or more 
units of blood products, usually packed red blood cells (PRBCs), within a 24-hour 
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period. It is performed whenever substantial resuscitation with primarily blood 
products is needed and can sometimes involve the infusion of several times a 
patient's original blood volume. A 1993 study in Australia found that 46% of MT 
recipients were victims of trauma, whereas the rest suffered from gastrointestinal 
bleeding or other disorders (Carr, 2004 ). This is not to imply that MT is 
commonly performed in the routine management of trauma patients. Typically, 
about 7% percent of combat casualties require MT as opposed to only 1-3% of 
civilian trauma patients (Holcomb et al., 2007). When needed , however, MT is 
extremely effective at restoring lost volume, improving the blood's oxygen 
carrying capacity, and improving systemic perfusion (Perkins et al. , 2008). 
Massive transfusion is sometimes conducted to keep pace with localized 
hemorrhage from one or several wounds , but it is also often required to treat 
diffuse, microvascular bleeding caused by coagulopathy (Hoffman , 2004 ). This 
systemic hemorrhage can occur immediately following injury or hours or days 
later. 
For all of its life-saving benefits, MT frequently causes its own 
complications. Some of these are due to the nature of blood transfusions in 
general , but many of them are the result of administering large volumes of stored 
blood products . Just as in regular transfusions , MT runs of the risk of causing 
acute hemolytic reactions when a patient's immune system identifies foreign 
antigens on the donor erythrocytes and attacks them . Massive transfusion 
carries an additional hazard related to immune response . Trauma patients often 
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initially receive 0 negative blood until their blood type can be determined. If a 
patient receives one or more units of 0 negative blood (which contains anti-A, 
anti-B, and anti-Rh antibodies), the patient can experience a hemolytic reaction 
much later when A or B antibodies are introduced with A, B, or AB blood 
infusions. These reactions can be dangerous to the MT recipient and are 
completely independent of his or her own immune system (Perkins et al. , 2008). 
A whole series of problems arises from the nature of stored blood. For 
starters, metabolism does not cease when blood is donated. Although they are 
stored at low temperatures to minimize its effects, PRBCs experience anaerobic 
metabolism that occurs continuously and makes them progressively more acidic. 
Whereas the normal pH of blood is 7.4 , recently collected PRBCs have an 
average pH of 7.16. After 21 days of storage pH falls to 6.78, and at 35 days of 
storage the average pH of PRBCs is 6.73. Thus, administering large volumes of 
acidic blood products to an already-acidotic patient will exacerbate coagulopathy 
and encourage persistent hemorrhage (Perkins et al. , 2008) . 
Beyond acidity, stored blood also develops electrolyte abnormal ities. As 
erythrocytes sit in storage, potassium gradually leaks from with in them into the 
extracellular fluid . After 7 days of storage, this concentration averages 12 mEq/L 
and increases to an average of 32 mEq/L after 21 days. The greatest risk to the 
trauma patient from hyperkalemia is cardiac arrhythmias, so one mitigation 
strategy is to administer blood products through a venous access site as far 
away as possible from the right atrium during MT. Another issue that arises with 
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stored blood is hypocalcemia. Citrate is added to blood products, where it binds 
calcium and prevents coagulation . Citrate is normally cleared by the liver, but 
citrate metabolism is impaired by hypoperfusion and hypothermia, common in 
trauma patients, as well as in patients with liver disease. MT may also 
overwhelm the liver's ability to metabolize citrate. The resultant citrate toxicity 
can cause prolonged QT intervals, hypotension , narrowing pulse pressures, 
muscle tetany, and predisposition to cardiac arrhythmias especially in the 
presence of hyperkalemia . Hypocalcemia from massive transfusion is more 
likely to occur from FFP and platelet infusions than PRBCs (Perkins et al. , 2008). 
Massive transfusion can also contribute to hypothermia. Most blood 
components are stored at 4°C, so administration of large volumes of chilled fluids 
can substantially lower core body temperatures. Once again , hypothermia is 
detrimental to patients because of its physiological effects including 
coagulopathy, decreased oxygen dissociation from hemoglobin, cardiac 
arrhythmias, decreased cardiac output, and increased overall risk of mortality. 
For these reasons, it is preferable to utilize fluid warmers when executing a MT 
resuscitation protocol (Perkins et al. , 2008) . 
Recommendations 
Once EMTs perform gross hemorrhage control measures like direct 
pressure, tourniquets, and hemostatic dressings, they can initiate other important 
and effective prehospital interventions. Sometimes, less is more; the success of 
99 
damage control resuscitation teaches that permissive hypotension is not just an 
acceptable treatment option, as is currently taught to EMTs. It is the preferred 
treatment. Optimally, blood pressure cuffs and cardiac monitors can be used to 
monitor systolic blood pressures and mean arterial pressures, respectively. The 
data suggest that a SBP of 80-90 mmHg or a MAP of 50-65 mmHg should be 
targeted. However, the combat medic's criteria of altered mental status and/or 
weak or absence radial pulses also serve as accurate clinical indications for fluid 
resuscitation. While multiple, large-bore IVs should be established in case of 
aggressive fluid resuscitation or MT, prehospital providers should limit the 
amount of crystalloids given to prevent hemodilution, electrolyte abnormalities, 
and coagulopathy while facilitating natural hemostatic mechanisms. The major 
contraindication for maintaining hypotension in trauma patients is confirmed or 
suspected head injury, where normal or elevated blood pressures can be critical 
for adequate perfusion of the brain. 
EMTs should also pay particular attention to temperature control of trauma 
patients. Hemorrhagic shock disrupts the body's ability to regulate temperature, 
and hypothermia is an indicator of both injury severity and risk of mortality. While 
this has long been known , it is now clear that hyperthermia is also undesirable in 
trauma patients. There are a variety of active and passive temperature 
regulation methods available in the prehospital environment: hot and cold packs, 
warmed and chilled IV fluids , blankets, heat, and air conditioning . By keeping 
core body temperature close to normal , the body's various physiologic 
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processes, from coagulation to cardiac output, are able to function at maximum 
efficiency. Temperature control methods should be strongly emphasized during 
initial and recurrent EMT training for management of hemorrhage. 
The last set of recommendations concerns massive transfusion patients. 
Although it is unlikely that prehospital providers will ever carry blood products in 
the civilian setting , they should be very familiar with the chemistry of stored blood 
and potential complications of massive transfusion. Many times, due to resource 
or staff limitations, marginally stable or unstable patients are transferred from one 
hospital to another. Paramedics, the prehospital advanced life support providers, 
frequently transport patients between emergency departments and intensive care 
units who are hemodynamically unstable and who are receiving infusions of 
blood products or vasoactive medications. Knowing that massive transfusion can 
result in delayed hemolytic reactions, acidosis, hyperkalemia, hypocalcemia, and 
hypothermia will allow them to anticipate coagulopathy, cardiac arrhythmias, and 
other adverse events. 
When time is not a factor, paramedics can better coordinate patient care 
plans for transport. Persistent acidosis and electrolyte abnormalities can be 
proactively managed with medications and continued massive transfusion to 
restore perfusion. Plasma is arguably the best intervention for addressing 
hemorrhagic coagulopathy, and it can be transported with the patient. When a 
patient needs to be emergently transferred for surgical intervention or a higher 
level of care, paramedics will be able to anticipate difficulties in resuscitation 
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should it become necessary. Cardiac arrhythmias and coagulopathy can be 
addressed with IV administration of sodium bicarbonate, calcium chloride , and 
other medications that are commonly carried prehospitally. 
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CONCLUSION 
This thesis set out to evaluate contemporary combat hemostasis methods 
as performed during Operations Enduring Freedom (in Afghanistan) and Iraqi 
Freedom (in Iraq) for efficacy and suitability in the civilian , prehospital setting. A 
range of invasive and non-invasive interventions were analyzed, including 
tourniquets, hemostatic dressings, pharmacological agents , damage control 
resuscitation, temperature management, and massive transfusion . Some of 
these methods should be adopted for use by civilian EMTs while others are 
unfavorable due to ineffectiveness, cost, or logistical hurdles. 
With hemorrhage control modalities becoming more complex and 
integrated , it is crucial that initial and recurrent training for prehospital providers 
include a thorough overview of normal hemostatic mechanisms and the 
coagulopathy that results from trauma in general and severe hemorrhage in 
particular. This knowledge will allow EMTs to better understand the physiologic 
states of their trauma patients and provide more effective, targeted patient care . 
The ever-increasing number of hemostatic products also necessitates a 
correspondingly broadened knowledge base to keep pace with evolving 
standards of care. 
Although emergency tourniquets have had a controversial past, recent 
ubiquitous military usage in conjunction with decades of surgical use suggest that 
they are safe , effective tools for stopping life-threatening limb hemorrhage. Many 
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of the traditional problems associated with tourniquet use were the result of 
inadequate tourniquet design (too narrow, improvised, etc.), prolonged ischemic 
times, or improper use. Wider tourniquets are preferable as they distribute 
pressure better throughout a limb, and they require less overall pressure to 
occlude arterial bleeding, the ultimate goal. Pneumatic tourniquets are preferred, 
and standard blood pressure cuffs have been shown to function very effectively 
as tourniquets . 
When tourniquet times are limited to 120 minutes or less, there are very 
few resultant complications. Tourniquets that are controlling life-threatening 
bleeding should never be loosened prehospitally as that leads to progressive 
exsanguination. However, when tourniquets are placed for tactical or logistical 
indications, such as mass casualty incidents or stabilization prior to vehicle 
extrication, EMTs should be trained to reassess their continued need when time 
and resources allow. In general, regular familiarization training is crucial for 
maintaining proficiency with tourniquet use. 
Despite relatively scarce data from human use beyond anecdotal claims , 
hemostatic dressing efficacy has been rigorously tested in animal models. These 
new dressings produce hemo.stasis in a variety of ways ranging from increasing 
clotting factor concentrations to forming gels. The most important factor in 
hemostatic dressing performance is old-fashioned direct, manual pressure; 
hemostatic dressings are hemostatic adjuncts and not replacements for standard 
hemorrhage control methods. This thesis recommends two hemostatic dressings 
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for prehospital use: Combat Gauze and Celox. CG can be packed into deep 
wounds or wrapped around large ones, and its kaolin coating activates natural 
clotting mechanisms, increasing the speed and strength of clot formation. ex is 
a granular agent that easily conforms to varying wound dimensions and makes 
good contact with damaged blood vessels. While it is more easily displaced by 
brisk, arterial bleeding, CX functions outside of the clotting cascade , allowing it to 
be effective in coagulopathic and anticoagulated patients. It also provides wound 
protection with chitosan-mediated antimicrobial properties. 
Several pharmacological interventions are geared towards combatting the 
anticoagulant and hyperfibrinolytic states found in trauma-associated 
coagulopathy. While rFVIIa is not efficacious in trauma patients, other 
procoagulant agents like prothrombin complex concentrates and freeze-dried 
plasma show great promise and may eventually wind up in the prehospital 
treatment arsenal. Tranexamic acid , however, has unequivocally demonstrated 
reduction in trauma patient mortality, especially when administered within three 
hours of injury. Since EMTs typically arrive on-scene within minutes of injury, 
TXA administration would likely be an extremely effective prehospital intervention 
in patients with severe hemorrhage. Other studies show promise for TXA in 
other situations, such as gastrointestinal bleeding and postpartum hemorrhage, 
so TXA may very well become a prehospital intervention for both traumatic and 
non-traumatic bleeding. 
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Several other considerations of trauma management were presented as 
well. The military has pioneered a very successful damage control resuscitation 
protocol that strives to quickly restore perfusion, minimize coagulopathy, and 
reduce morbidity and mortality following traumatic hemorrhage. While 
prehospital providers are unlikely to routinely administered blood products, 
several lessons from OCR are directly applicable. Although it is now 
"acceptable" for EMTs to practice permissive hypotension, data suggest that 
systolic blood pressures should be maintained at around 80-90 mmHg to 
promote both clot formation and perfusion. Conveniently, an SBP in this range 
can be evaluated quantitatively via blood pressure readings or qualitatively by 
mental status and presence/strength of radial pulses. Restoration of adequate 
perfusion is the best definitive treatment for coagulopathy, but prehospital 
crystalloid administration should be limited to what is necessary to maintain the 
aforementioned blood pressure. Normal saline and lactated ringer's are not as 
benign as once thought; they contribute to electrolyte disturbances, hemodilution , 
coagulopathy, and immune system responses. 
Since severely injured patients lose the ability to regulate temperature, 
temperature management of trauma patients is critical. Both hypothermia and 
hyperthermia are associated with increased mortality, and maintaining a patient's 
core body temperature in a normal range allows clotting enzymes to work in their 
optimum environment. There are a number of simple active and passive 
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methods of warming and cooling patients in the prehospital setting, and they 
should not be overlooked as efficacious interventions. 
Finally, patients who are being transferred between hospitals after or while 
receiving massive transfusion should be closely monitored and lab values should 
be obtained prior to transport whenever possible. MT of stored blood products 
can cause substantial downstream complications such as acidosis, 
hyperkalemia, hypocalcemia, hypothermia, coagulopathy, and delayed hemolytic 
reactions. A more thorough understanding of the properties of stored blood will 
allow the paramedics performing these transfers to better understand the 
coagulability of their patients and to anticipate potential adverse events like 
cardiac arrhythmias. 
Many civilians and combatants have been killed or injured as a result of 
the fighting in OEF and OIF. Both the number and severity of injuries have 
allowed military medical personnel to develop and test these new hemostatic 
methods. From the data currently available , several efficacious interventions 
have been recommended for civilian use. As time goes on and more studies are 
published , especially those concerning hemostatic dressing performance in 
humans, there will likely be more and different recommendations. Civilian 
prehospital management of trauma patients, especially those with severe 
hemorrhage, has benefited and will continue to benefit from these advances. 
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